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                                                    CHAPTER I 
INTRODUCTION 
Medicinal Plants [1-3] 
 A plant is any plant which, in one or more of its organs, contains substances that can 
be used for therapeutic purposes, or which are precursors for semi-synthetic compounds. 
When a plant is designated as ‘medicinal’, it is implied that the said plant is useful as a drug 
or therapeutic agent or an active ingredient of a medicinal preparation. Medicinal plants may 
therefore be defined as a group of plants that possess some special properties or virtues that 
qualify them as articles of drugs and therapeutic agents, and are used for medicinal purposes. 
History of medicinal plants  
Plants have been used for medicinal purposes from 5000 BC with the emergence of 
the Indus Valley Civilization. The indigenous system of medicine, viz.-Ayurvedic, Siddha 
and Unani, have been in existence for several centuries. The country has 45,000 different 
plant species and 15000 medicinal plants that include 2000 plants used in Ayurveda, 700 in 
Unani, 600 in Siddha, 450 in Homoeopathy and 30 in modern medicines. The drugs are 
derived either from the whole plant or from different parts like leaves, stem, bark, root, 
flower, seed etc. Some drugs are prepared from excretory plant product such as gum, resins 
and latex.  
Significance of medicinal plants to human beings  
(1) Many of the modern medicines are produced indirectly from medicinal plants, for 
example aspirin.  
(2) Plants are directly used as medicines by a majority of cultures around the world, 
for example Chinese medicine and Indian medicine.  
(3) Many food crops have medicinal effects, for example garlic.  
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(4) Medicinal plants are resources of new drugs. It is estimated there are more than 
250, 000 flower plant species. 
Hence studying medicinal plants helps to understand plant toxicity and protect human 
and animals from natural poisons. Cultivation and preservation of medicinal plants protect 
biological diversity, for example metabolic engineering of plants. 
Future of medicinal plants  
Medicinal plants have a promising future because there are about half million plants 
around the world, and most of their medical activities have not been investigated yet, and 
their pharmacological activities could be decisive in the treatment of present or future studies. 
Characteristics of medicinal plants  
Medicinal plants have many characteristics when used as a treatment, as follow: 
 Synergic medicine - The ingredients of plants all interact simultaneously, so their 
uses can complement or damage others or neutralize their possible negative effects. 
 Support of official medicine - The components of the plants proved to be very 
effective in the treatment of complex cases like cancer diseases. 
 Preventive medicine - It has been proven that the component of the plants also has 
the ability to prevent the appearance of some diseases which can help to reduce the 
use of the chemical remedies and reduce the side effect of synthetic treatment. 
Medicinal plants in India  
 About 60 percent of the world’s population use herbal medicines. Herbal medicines 
are not only used for primary health care not just in rural areas in developing countries, but 
also in developed countries as well where modern medicines are predominantly used.  
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There are about 45,000 medicinal plant species in India, concentrated in the region of 
Eastern Himalayas, Western Ghats and Andaman & Nicobar Island. The officially 
documented plants with medicinal potential are 3000 but traditional practitioners use more 
than 6000 plants. India is the largest producer of medicinal herbs and is called the botanical 
garden of the world. 
 Ayurveda and Kabiraji (herbal medicine) are two important forms of alternative 
medicine that is widely available in India. Ayurveda form of medicine is believed to be 
existent in India for thousands of years. 
 The codified traditions have about 25,000 plant drug formulations that have emerged 
from such studies. In addition to this, over 50,000 formulations are believed to be available in 
the folk and tribal traditions. All these point to the deep passion for an exhaustive knowledge 
about medicinal plants that have existed in this land from time immemorial. 
Importance of Medicinal Plants [4] 
The medicinal plants find application in pharmaceutical, cosmetic, agricultural and 
food industry. The use of the medicinal herbs for curing disease has been documented in 
history of all civilizations. Man in the pre-historic era was probably not aware about the 
health hazards associated with irrational therapy. With the onset of research in medicine, it 
was concluded that plants contain active principles, which are responsible, for curative action 
of the herbs.    
 Integrating the use of Traditional medicine (TM) in the treatment of incurable disease 
such as AIDS to boost immunity is wiser than waiting for the immune system to weaken to 
begin antiviral therapy as is the common practice, especially when evidence exists that 11 of 
the anti infective herbs in Chinese TM have shown to be anti-HIV. 
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According to the WHO, 25% of modern medicines are made from plants first used 
traditionally. One recent example is the use of Artemisinin based drugs for treating malaria 
due to the malaria parasite exhibiting drug resistance to previously prescribed drug therapies. 
Traditional Chinese medicine has been used to effectively treat malaria with cultivated 
Artemisia plants for over 2500 years. 
In South Africa, the medical research council is conducting studies on the efficacy of 
the plant Sutherlandia microphylla in treating AIDS patients. Traditionally used as a tonic, 
this plant may increase energy, appetite and body mass in people living with HIV. 
Diabetes mellitus is another area where a lot of research is going on. Ajuga reptens 
(the active principle is said to potentiate effects of insulin), Galagea officinalis (galagine), 
Bougainvillea spectabilis (pinitol), Momordica charantia (chirantin), Gymnema sylvestre 
(gymnemic acid) are some medicinal herbs that have shown effectiveness in non-insulin 
dependent diabetes. Recently extract of Tecoma stans has shown potent anti diabetic activity. 
Alkaloid tecomonine is considered to be active principle of the herb. 
Arthritis is another potential disease where no satisfactory answer is present in 
modern medicine. Commiphora mukul (guggulsterones), Boswellia serrata (boswellic acid), 
Withania somnifera (withanolides), Ruscus acueleatus (ruscogenin) are prominent plants with 
anti-arthritic activity. 
Croton sublyratus (plaunoyol) has potent and wide spectrum anti peptic ulcer action.  
Ancistrocladus korupensis (michellammine-b), Caulophyllum langigerum (calanolide-A), 
Caulophyllum teymani (costatolide-A), Homalanthus natans (prostratin) are the medicinal 
herbs from African countries that are being employed in research for finding a suitable cure 
for Aids. 
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Some Common Major Diseases [5] 
Some common major disease described by the Dirnasa tribe are jaundice, diabetes, 
high blood pressure, urinary tract infection, carbuncles, cardiac problem, cancer, hearnaturia. 
Malaria, filariasis, Japanese encephalitis, dengue hemorrhagic fever, chikungunya and yellow 
fever are transmitted by mosquitoes which cause millions of deaths every year.  
Modern medicine discovered from plants [6]  
Plants provide biologically active molecules and lead structures for the development 
of modified derivatives with enhanced activity and reduced toxicity. The small fraction of 
flowering plants that have so far been investigated have yielded about 120 therapeutic agents 
of known structure from about 90 species of plants. Some of the useful plant drugs include 
vinblastine, vincristine, taxol, podophyllotoxin, camptothecin, digitoxigenin, gitoxigenin, 
digoxigenin, tubocurarine, morphine, codeine, aspirin, pilocarpine, capscicine, allicin, 
curcumin, artemesinin and ephedrine among others. In some cases, the crude extract of 
medicinal plants may be used as medicaments. About 121 (45 tropical and 76 subtropical) 
major plant drugs have been identified for which no synthetic one is currently available. 
It has been estimated that more than 400 traditional plants or plant-derived products 
have been used for the management of type 2 diabetes across geographically. Galegine, a 
substance produced by the herb Galega officinalis, provides an excellent example of such a 
discovery. Experimental and clinical evaluations of galegine, provided the pharmacological 
and chemical basis for the discovery of metformin which is the foundation therapy for type 2 
diabetes. Plant derived agents are also being used for the treatment of cancer. Several 
anticancer agents including taxol, vinblastine, vincristine, the camptothecin derivatives, 
topotecan and irinotecan, and etoposide derived from epipodophyllotoxin are in clinical use 
all over the world. 
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The use of herbal products is of global importance because of their low side effects, 
accessibility and affordability when compared with conventional medicine. 
Advantages of Herbal Medicines compare with alternative therapy [7-8] 
Herbal medicine has been used for centuries to treat many different health conditions. 
As with most types of complementary or alternative therapy, people may use it to help 
themselves feel better or feel more in control of their situation. Herbal medicine is often 
promoted as a natural way to help you relax and cope with anxiety, depression and other 
conditions such as hay fever, irritable bowel syndrome, menstrual (period) problems and skin 
conditions such as eczema. 
In India it is proving to be a major health problem, especially in the urban areas. Though 
there are various approaches to reduce the ill effects of diabetes and its secondary complications, 
herbal formulations are preferred due to lesser side effects,  low cost, widely available and    less 
toxic  compared with allopathic drugs. 
CITRULLUS LANATUS (Watermelon) [9] 
Citrallus lanatus (water melon) produces a fruit that is about 93% water, hence the 
name “water” melon. The “melon” part came from the fact that the fruit is large and round 
and has a sweet, pulpy flesh. The scientific name of the watermelon is derived from both 
Greek and Latin roots. The Citrullus part comes from a Greek word “citrus” which is a 
reference to the fruit. The lanatus part is Latin, and has the meaning of being wooly, referring 
to the small hairs on the stems and leaves of the plant (Baker, et al., 2012). Watermelon is 
thought to have originated in southern Africa because it is found growing wild throughout the 
area, and reaches maximum diversity of forms there. It has been cultivated in Africa for over 
4,000 years. Citrullus lanatus was brought to America by Spanish and quickly became very 
popular crop (Robinson and Decker, 1997). 
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 Citrullus lanatus (Water melon) has been reportedly used widely in traditional 
herbal medicine. The fruit is used as a febrifuge, diuretic, purgative and used 
in treatment of diarrhoea, gonorrhoea, dropsy and renal stones. 
 The leaves of Citrullus lanatus is analgesic, anti-inflammatory, mosquitocidal, 
gonorrhoea and anti microbial property.  
 The fruit is also diuretic, anti-cancer, high BP, antiviral and is effective in the 
treatment of dropsy and renal stones. The seed is also a good vermifuge and 
has a hypotensive action. Preliminary research indicates that the consumption 
of watermelon may have antihypertensive effects. 
 The root is purgative and in high dose it can also serve as emetic.  
 The seed is a good vermifuge and has a hypotensive action. It is a demulcent 
and used in the treatment of the urinary tract infections as well as bed wetting. 
 Fatty oil in the seed, as well as aqueous or alcoholic extracts, had been 
reported to paralyze tapeworms and roundworms.  
 The rind of the fruit is prescribed in cases of alcoholic poisoning and  
 The plant Citrullus lanatus has been selected (specially the leaves) for the present 
investigation on the basis of the ethnomedical information and the review of literature as the 
plant is widely cultivated throughout India. 
 
  
  
 
 
REVIEW OF 
LITERATURE 
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CHAPTER II 
REVIEW OF LITERATURE 
 
 A literature review is an evaluative report of studies found in the literature related to 
the selected area of research. The review describes, summarizes, evaluates and clarifies the 
literature available in the present research. It is a step towards further investigation on a 
particular work. It denotes with works derived from primary and secondary sources. 
Mallavarapu GR and Rao LR (1979) isolated the chemical constituents of some 
Cucurbitaceae plants including Citrullus colocynthis. Cucurbitacin B,E and I and 
Cucurbiracin-E-2-glycoside were isolated from Citrullus colocynthis.[10] 
Tripathi SN et al., (1980) evaluated the hypoglycemic activity of certain indigenous 
drugs including Citrullus colocynthis in rabbits. The response of these drugs on glucose 
induced hyperglycaemia. [11] 
Itoh T et al., (1981) has demonstrated the co-occurrence of the C-24 epimers 
spinasterol and chondrillasterol in seeds of Citrullus lanatus (Cucurbitaceae) and seeds of 
bottle guard (Langenaria leucantha var. gourda) by 13C NMR spectroscopy method.[12] 
Yohora SB and Khan MSY (1981) studied the diuretic activity of Albizzia lebbeck 
(seeds saponin), A. odoratissima (seeds, saponin), Annona squamosa (seeds), Cicer arietinum 
(seed coat), Citrullus colocynthis (seeds), Lepidium sativum (seeds), Nigella sativa (seed, 
seed oil), Ochrocarpus longifolius (flowers, flavonoids), Peucedanum grande (seed, oil), 
Solanum xanthocarpum (seeds, saponin), Taxus baccata (leaves) and vitex nigando in rats 
when compared to that of urea. The seed coat of Cicer arietinum and T. baccata exhibited 
maximum diuretic activity.[13] 
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Hussein Ayoub SM and Yankov LK (1981) isolated 8 components from peels of 
Citrullus colocynthis (Cucurbitaceae) by column chromatography and preparative TLC. The 
less polar component represented an alkaline mixture (mp 38-42°C).[14] 
Hussein Ayoub SM and Yankov LK (1981) examined the free hydroxyl and 
carbonyl components mixture from the petroleum ether fraction of Citrullus colocynthis peels 
by GLC.[15] 
Nag TN and Harsh ML (1982) reported the presence of steroidal sapogenins viz., 
diosgenin, tryptogenin, lanosterol and beta sitosterol from various parts of Citrullus 
colocynthis (Cucurbitaceae).[16] 
Hussein ASM and Yankov LK (1983) isolated the two isomers of 11,14 dimethyl 
hexadecane -14-ol-2-one (C18H36O8) from petroleum ether extract of Citrullus colocynthis 
fruit peels (Cucurbitaceae).[17] 
Harsh ML et al., (1983) studied the antimicrobial activity of petroleum ether and 
50% ethanolic extract of roots, shoot and fruits of Citrullus colocynthis against 
Staphylococcus aureus, E. coli and Candida albicans. The extracts were found to be effective 
against the tested organisms. [18] 
Pandey P et al., (1985) evaluated the effect of livol (R) a formulation on some 
biochemical parameters in relation to improvement of liver function. The composition of 
herbal drug include Citrullus colocynthis administered orally exhibited protective hepatotoxic 
activity in experimental dogs.[19] 
Garg VK and Nes WR (1986) studied the sterol composition of 13 components of 6 
Cucurbitaceae seeds including Citrullus lanatus. They were codisterol, 25 (27)-
dihydroporiferasterol, clerosterol, isofucosterol, stigmasterol, campesterol, 22 (27)-
dehydrochondrillasterol, 24-β-ethyl-25(27)-dehydrolathosterol, avenasterol, spinasterol, 24 
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epsilon methyl lathosterol and 22-dihydrospinasterol, 24-methylene cholesterol (small 
quantities). δ-5-sterol were noticed in all the species.[20]. 
Sushil Kumar et al., (1997) have reported the antibacterial activity of seeds 40 plant 
species including Citrullus vulgaris (Cucurbitaceae). The antibacterial activities of the seeds 
of 36 plant species were tested against Pseudomonas cichorii, Bacillus substilis, Salmonella 
typhimurium and E. coli. Citrullus vulgaris showed larger inhibition zones than the other 
tested species.[21] 
Ziyyat A et al., (1997) studied antidiabetic activity of 41 plants including Citrullus 
colocynthis (Cucurbitaceae). The most used plants included Trigonella foerumgraecum, 
Globularia alypum, Artemisia herbaalba, Citrullus colocynthis and Terraclinis articulate. In 
the hypertension’s therapy 18 vegetal species were reported, of which the most used were 
Allium sativum, Olea europea, Arbutus unedo, Urtica dioica and  petroselinum crispum. 
Among the 18 species used for hypertension, 14 were also employed for diabetes. Moreover 
these two diseases were associated in 41% of hypertensives. These findings suggest that 
hypertension observed in this region would be in a large part related to diabetes.[22] 
Rizvi MA et al., (1998) discussed the medicinal uses of some poisonous plants 
including Citrullus colocynthis (Cucurbitaceae) and also discussed botanical description, 
distribution, chemical and poisonous constituents.[23] 
ESJ Nidiry (1998) studied the antifungal activity of various extracts of seeds of 
Citrullus lanatus. The methanolic extract exhibited higher activity against mycelial growth of 
Collectotrichum gloeosporiodes while the petroleum ether extract had higher activity against 
spore germination of Cladosporium cucurmerinum.[24] 
Bhujbal MM (1999) studied the management of 50 cases of various skin diseases. 
They were treated with decoction mixture of Trichosanthus, Citrullus colocynthis, Gentiana 
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kurroo, Terminalia chebula and Zingiber officinale at a dose of  20-40mL on empty stomach 
with hot water and honey for 4-6 weeks. It  was useful and no side effects were observed.[25] 
Billore KV et al., (2000) studied the ethnobotanical lores in birth control of some 
species including Citrullus species, practiced traditionally by the tribals of Rajasthan in 
western India. The study may play a vital role in the prospective national birth control 
programme of the country.[26] 
Ayangarya VS (2000) studied the treatment of all type of skin disease cured by the 
fruit juice of Citrullus colocynthis. The boils on the skin have been cured by applying the 
fruit juice on the body. A lotion was prepared from the fruits of cucumis and skin care 
benefits were also felt by the urbanites. Even, powder can be prepared from the fruits of this 
plant for the treatment during unseasonal days.[27] 
Anuradha V et al., (2000) examined the highest larvae mortality of petroleum ether 
and benzene extract of 6 plants including Citrullus colocynthis. Highest mortality was 
observed in seed extract of Citrullus colocynthis. The percentage of adult emergene was 8.3.  
Extended larval periods, low fecuding and 100% mortality of second generation larvae were 
also observed.[28] 
Al-yahya MA (2000) studied the toxicity of 10% of Citrullus colocynthis fruits or 
10% of Nerium oleander leaves or their 1:1 mixture in rats. Dullness, ruffled hair, decreased 
body weight gains and feed efficiency and entero hepatoneuropathy characterized treatment 
with Citrullus colocynthis and Nerium oleander given alone. Diarrhea was a prominent sign 
of Citrullus colocynthis. Feeding the mixture of above two drugs caused more effect and 
death of rats.[29] 
Shantha et al., (2001) have studied the pharmacognostic features of the seeds of 
Citrullus lanatus. They have described macroscopy, microscopy, histochemical tests, 
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solubility, physical constants, extractive values, and test for inorganic and organic 
constituents, UV and TLC studies of the seeds of Citrullus lanatus.[30] 
Pino et al., (2003) have isolated the volatile oil components of Citrullus lanatus fruit 
by simultaneous steam distillation/solvent extraction method. The fruit had 7.6mg/kg of total 
volatile compounds.[31] 
Bendjeddou D et al., (2003) studied the immuno stimulating activity of the hot water 
soluble polysaccharide extract of 3 plants including Citrullus colocynthis. The extract of 
Citrullus colocynthis showed weaker immune stimulating activity to Anacyclus pyrethrum 
and Alpinia galanga which showed a marked stimulating effect on the reticulo endothelial 
system.[32] 
Paudel RC et al., (2003) reported the anti-hepatitis activity of 44 plant species 
included Citrullus colocynthis and also tested the antiviral activity of this plant in China and 
India.[33] 
Mukherjee A et al., (2003) evaluated the hepatoprotective activity of Citrullus 
colocynthis root against carbon tetrachloride induced toxicity in albino rats. Hepato-
protective activity of different extracts of Citrullus colocynthis L. Sch. (roots) 
(Cucurbitaceae) was investigated in albino rats by inducing hepatotoxicity with carbon 
tetrachloride. The alcoholic extract of Citrullus colocynthis Sch. 100 mg/kg b.w. has been 
shown to posses significant hepatoprotective effect by lowering the serum level of 
transaminases (GPT and GOT), alkaline phosphate (ALP) and bilirubin (P < 0.05 to P < 
0.001).[34] 
Goswami DN (2003) examined the fatty acid composition of seeds of Citrullus 
colocynthis by various chromatographic and spectral technique.[35] 
Fukushige H and Hilderbrand DF (2005) compared the highest hydroperoxide 
lyase enzyme activity of Citrullus lanatus (Cucurbitaceae) leaves with Nicotiana tobaccum 
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(Solanaceae) in transgenic leaves (50 times higher than endogenous HL activity). The 
enzyme is 3 times more active with 13-hydroperoxylinolenic acid than with 13-
hydroperoxylinoleic acid. The activity against 9-hydroperoxides of polyunsaturated fatty acid 
is minimal when compared with Arabidopsis HL also expressed in N.tobaccum the highest 
HL activity is 10 time higher in watermelon.[36] 
Kozan E et al., (2006) have evaluated the in vivo anthelmintic activity of ethanolic 
and aqueous extract of 9 plant species including Citrullus lanatus against pinworm, Syphacia 
obvelata and Aspiculiris tetraptera in mice. The ethanolic and aqueous extracts of Citrullus 
lanatus showed anthelmintic activity.[37] 
Perkin S et al., (2006) have determined the carotenoid content (84.97%) of Citrullus 
lanatus by HPLC method and lycopene content of Citrullus lanatus by colorimetric assay. 
The total lycopene content was used to separate watermelon cultivars into low (more than 
50mg/kg fw), average (50-70mg/kg fw), high (70-90mg/kg fw), and very high (less than 
90mg/kg fw). Cultivars varied  greatly in lycopene content, ranging from 33 to 100mg/kg).[38] 
Jabbar A et al., (2006) reported the inventory of the ethnobotanical used as 
anthelmintics in southern Punjab (Pakistan). 3 stage process was used to document the plants 
being used to treat and/or helminthosis in ruminants. The main plants used were Lamium 
amplexicaule, Mallotus philippinensis, Withania somnifera, Azadirachta indica and Citrullus 
colocynthis. The study provided a foundation for the scientific study and verification of those 
plants used as anthelmintics.[39] 
Nayab D et al., (2006) isolated the cucurbitacin glycoside from Citrullus colocynthis 
(Cucurbitaceae). A new cucurbitacin glucoside 2-O-β-D-glucopyranosyl-16α-20R-dihydroxy-
cucurbita-1,5,23E,25(26)-tetraen-3,11,22-trione (1) has been isolated from the methanolic 
extract of the fruits of Citrullus colocynthis. The structure has been assigned on the basis of 
spectral analysis including 1D and 2D NMR techniques. In addition 2-O-β-D-
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glucopyranosyl-cucurbitacin B (arvenin I) (2) and 2,25-di-O-β-D-glucopyranosyl-
cucurbitacin L (3) are reported for the first time from this species.[40] 
Sharma M and Vats S (2007) collected the ethnobotanical survey of digestive 
disorder cure plants. 16 species oncluding Citrullus colocynthis (Cucurbitaceae) were used by 
the tribal people of Rajasthan for curing digestive disorders.[41] 
Qureshi R and Bhatti GR (2007) studied the Citrullus colocynthis medicinal 
properties used in traditional system of medicine i.e. Unani, Ayurvedic and Homeopathic. Its 
purgative action was due to the presence of alkaloids. This plant is commonly used for 
digestive complaints in human beings and livestock by traditional users in Nara desert, 
Pakistan. The medico ethno-botanical survey presented describing phytochemistry, medicinal 
properties, description and distribution of plants.[42]   
Khowri NA et al., (2007) studied the effect of aqueous extract of Citrullus 
colocynthis (Cucurbitaceae) leaves on the lipid profile and other biochemical parameters on 
Albino rats. The extract showed decreases in total serum cholesterol level and decrease in 
blood level of both serum alanine and serum creatine kinase (p ≤ 0.05) and increase in serum 
lactate dehydrogenase (p ≤ 0.01) by oral administration of the extract to albino rats at a dose 
500mg/kg for 7 days.[43] 
Joshua AJ et al., (2007) examined the lipotropic activity of Natchol, a polyhedral 
formulation containing Solanum nigrum (Solanaceae), Citrullus colocynthis 
(Scrophulariacea), Sida cardifolia (Malvaceae) and Boerhaavia diffusa (Nyctaginaceae). The 
formulation was administered orally at 100 mg/kg b.w. while choline chloride was given at 
the dose of 200mg/kg b.w for 7 days prior to carbon tetrachloride treatment in albino wistar 
rats. Natchol treatment significantly reduced the hepatic triglyceride level and reduction in 
weight gain induced by carbon tetrachloride. The histopathological examination further 
confirmed the lipotropic activity.[44] 
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Aburjai T et al., (2007) studied the ethno-pharmacological survey of medicinal herbs 
including Citrullus colocynthis in Jordan, the Ajloun height region. The use of moderately 
unsafe or toxic plants by traditional healers was noted. These plants include Ecballium 
elaterium, Euphorbia hierosolymitana, Mandragora autumnalis and Citrullus colocynthis. 
Kidney problems scored the highest informant concensus factor (ICF) while Cracus heymalis 
was the plant of highest use value.[45] 
Mukherjee A et al., (2007) evaluated the activity of alcoholic aqueous extract of 
roots of Citrullus colocynthis against carbon tetrachloride induced hepatotoxicity in albino 
rats. The extract showed a significant hepatoprotective activity.[46] 
Yoshikava M et al., (2007) isolated the two new Cucurbitane type triterpene 
glycoside colocynthoside A and B with 17 known constituents and Cucurbitacin E2-O-β-D-
glucopyranoside from methanolic extract of Citrullus colocynthis (Cucurbitaceae). The 
Cucurbitane type triterpene glycoside, Cucurbitacin E2-O-β–D-glucopyranoside and its 
aglycone, Cucurbitacin E exhibited antiallergic activity at 100 and 1.25mg/kg, p.o., 
respectively.[47] 
Meena MC and Parni V (2008) isolated and identified the flavonoid “quercetin” 
from various solvent extractions of leaf, stem, fruit and root of Citrullus colocynthis 
(Cucurbitaceae). The purified material was subjected to IR, HPLC and identified as 
quercetin. The Rf value of isolated quercetin and standard quercetin was compared.[48] 
Sunil Kumar et al., (2008) evaluated the phytochemical screening of methanolic 
extract of fruits of Citrullus colocynthis (Cucurbitaceae). The plant showed higher amount of 
phenolic and flavonoids. The phenolic content was 0.74% (calculated at gallic acid) and 
0.13% of flavonoid  calculated as catechin equivalents per 100g of fresh mass and antioxidant 
activity was evaluated and free radical scavenging effect also evaluated. The IC50 of the 
extract was found to be 2500µg/mL.[49] 
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Allali H et al., (2008) studied the most useful hypoglycemic activity of more than 58 
plants including Citrullus colocynthis (Cucurbitaceae). The results gathered from 634 injury 
forms (435 women and 199 men) were separated into two groups; diabetic using medicinal 
plants (62%) and industrial hypoglycemic medicines (38%). The finding also showed non-
insulin dependent patient used more medicinal plants than insulin dependent patients.[50] 
Benmehdi H et al., (2008) studied the hypo and anti hyperglycemic effect of the 
seeds of Citrullus colocynthis. Intra peritoneal administration of the aqueous extract 1.25g/kg 
to streptozotocin induced diabetic rats produced reduction of blood sugar level in long term 
while the same extract produced no alteration of glycaemia in normal rats in short term. The 
extract has maximal adverse effect and high LD 100 value.[51] 
Sangameswaran B et al., (2008) studied the oral hypoglycemic activity of both 
aqueous and methanolic extracts of leaves of Citrullus colocynthis (Cucurbitaceae) in 
experimental animal (dose 500mg/kg). The standard anti diabetic agent, glibenglamide 
(500mg/kg) used to compare in this activity. The results indicate significant anti diabetic 
activity by both the test extracts (p ≤ 0.01).[52] 
Dineshkumar B et al., (2009) reviewed the anti diabetic activity of common Indian 
plants including Citrullus colocynthis. These may act on beta cells of the pancreas and 
stimulate the secretion of insulin, inhibits α-cells for the release of hypoglycemic factors, 
enhance the effect insulin, inhibit the synthesis of glucose 6-phosphate phosphatase, fructose 
diphosphatase, pyruvate carboxylase of phosphoenol pyruvate carboxykinase and stimulate 
the synthesis of glucokinase.[53] 
Dhanotia R et al., (2011) evaluated the effect of Citrullus colocynthis Schrad fruits 
for hair growth in androgen induced alopecia. The petroleum ether extract was applied 
topically. Alopecia was induced in albino mice by simultaneous administration of extract 
were evaluated using follicular density, anagen/telogen (A/T) ratio and microscopic 
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observation of skin section. Petroleum ether extract of (Citrullus colocynthis) exhibited 
promising hair growth promoting activity, as reflected from follicular density, A/T ratio and 
skin sections. The treatment was also successful in bringing a greater number of hair follicles 
in anagenic phase than the standard Finasteride. The result of treatment with 2 and 5% 
petroleum ether extracts were comparable to the positive control Finasteride.[54] 
Upadhyay B et al., (2011) reported the ethno-veterinary uses and informants 
consensus factor of medicinal plants of Sariska region, Rajasthan, India. The highest ICF 
(0.61) was scored for digestive problem. Citrullus colocynthis used for fever and general 
sickness with a highest use value (UV) of 0.62.[55] 
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CHAPTER III 
AIM AND SCOPE OF THE PRESENT STUDY 
 The use of herbal products is global importance because of their low side effects, 
accessibility and affordability when compared with conventional medicine. Citrallus lanatus 
(watermelon) is popular in indigenous system of folk medicine and it is known to contain 
bioactive compounds such as cucurbitacin, triterpenes, sterols and alkaloids, vitamins, 
minerals. 
Citrullus lanatus has been reportedly used widely in traditional herbal medicine.  The 
leaves of Citrullus lanatus is analgesic, anti-inflammatory, mosquitocidal, gonorrhoea and 
anti microbial property. The fruits of Citrullus lanatus are eaten as a febrifuge when fully 
ripe or even when almost putrid. The fruit is used as a diuretic, anti-cancer, for treatment of 
high BP, antiviral and is effective in the treatment of dropsy and renal stones. The seed is 
also a good vermifuge and has a hypotensive action. It is demulcent, pectoral and tonic. It is 
sometimes used in the treatment of the urinary tract infections as well as bed wetting. The 
root is purgative and in high dose it can also serve as emetic.  Fatty oil in the seed, as well 
as aqueous or alcoholic extracts, had been reported to paralyze tapeworms and roundworms. 
The rind of the fruit is prescribed in cases of alcoholic poisoning and diabetes. Citrullus 
lanatus is used in Northern Sudan for burns, swellings, rheumatism, gout and as laxative. 
The biological activities reviewed include antimicrobial, antioxidant, anti-plasmodial, 
anti-inflammatory, anti-prostatic hyperplasia activity, antigiardial activity, anti-oxidant, 
analgesic properties, its effects on the histology of the kidney of adult Wistar rats, 
antisecretory, antidiabetic, laxative, antiulcerogenis and hepatoprotective activities. In view 
of its wide pharmacological and biological activities, it’s traditionally reported therapeutic 
potential such as, antihypertensive, anti diarrhoeal, as well as its in-depth toxicity studies, 
among others, are yet to be experimented. 
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The species of Citrullus such as Citrullus colocynthis have already reported anti-
cancer (breast cancer) activity. 
Based on the ethnomedical information and studies available, the present research 
work has been framed to carry out the following studies on the leaves of Citrullus lanatus. 
I. Pharmacognostical Evaluation 
 Macroscopical evaluation and Microscopical Evaluation. 
 Microscopical evaluation 
   Standardization parameters 
 Quantitative Analytical parameters. 
 Powder  Microscopy and Fluorescence analysis of powder and extracts. 
II. Phytochemical Evaluation 
 Preliminary phytochemical screening.  
 Quantitative estimation of some secondary metabolites present in the plant. 
 TLC and HPTLC finger print analysis. 
III. Pharmacological evaluation 
    1.  In-vitro antioxidant activity by various methods 
 Scavenging of 2,2-Diphenyl-1-picrylhydrazyl (DPPH) radical 
 Total antioxidant activity by Phosphomolybdenum Method.  
 Reducing power assay  
 Ferric Reducing Antioxidant Power Assay (TPTZ method).  
                     2.  Larvicidal activity of methanolic extract of Citrullus lanatus. 
                     3.  In vitro activity of chicken pancreatic lipase inhibition Assay. 
                     4.  In vitro anti-cancer (Breast cancer) activity by MTT assay. 
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                     5.  In vitro Anti-diabetic activity by various methods 
 Non-enzymatic glycosylation of haemoglobin Assay. 
 Glucose uptake in yeast cells 
 % inhibition of Glucose uptake in 5mM  and 10mM glucose 
concentrations 
 Alpha amylase inhibition assay. 
 Alpha glucosidase inhibition assay 
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CHAPTER IV 
    PLANT PROFILE[56-59] 
DESCRIPTION  
It is an annual climbing or trailing herb, with hairy stem up to 10m long. Tendrils 
divided at the tip into two or three parts. Separate male and female flowers are borne on the 
same plant. 
Botanical Source: Citrullus lanatus (Thunb). Matsum. & Nakai 
Family:  Cucurbitaceae 
Synonyms: Citrullus vulgaris Schrad., Colocynthis citrullus Linn., Citrullus citrullus (L.), 
Cucubertia citrullus L., Anguria citrullus Mill., Momordica lanata Thunb. 
Common Names: Watermelon, wild watermelon, sweet melon (English); Egusi melon 
(English, Kenya); pastèque, melon d’eau (French).   
Vernacular Names  
Malaysia     :  Tembikai 
English        :  Watermelon 
India           :   Karingda 
Chinese       :   Da zi gua zi xi gua. 
Tamil           :  Pitcha. 
Sanskrit       :  Tarambuja. 
Hindi           :  Tarbuj  
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General   
Symbol            : CILAL 
Group              : Dicot 
Family              : Cucurbitaceae 
Duration          : Annual 
Growth habit  : Vine Forb/ herb 
GEOGRAPHY & DISTRIBUTION:  Citrullus lanatus is thought to be native to Africa. It 
is found in grassland and bushland, mostly on sandy soils, and often along watercourses or 
near water, up to 1,785 m above sea level. It flourishes in dry climates and requires only 
limited rainfall. Some say that the Kalahari region (Botswana, Namibia and South Africa) as 
the area of origin, whereas others suggest it is native to north eastern Africa.  
HABITAT: Grassland and bushland, often along watercourses. 
Classification:  
Kingdom                     :  Plantae - Plants 
Subkingdom                :  Tracheobionta - Vascular plants 
Superdivision              :  Spermatophyta - Seed plants  
Division                       :  Magnoliophyta  - Flowering plants 
Class                            :  Magnoliopsida – Dicotyledons 
Subclass                       :  Dilleniidae 
Order                           :  Violales 
Family                          :  Cucurbitaceae  
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Genus                           :  Citrullus Schard - watermelon 
Species                         :  Citrullus lanatus (Thunb.) Mastum. & Nakai var lanatus  
ETHNOMEDICAL USES   
(1) Citrullus lanatus has been reportedly used widely in traditional herbal medicine. The 
fruits of Citrullus lanatus are eaten as a febrifuge when fully ripe or even when 
almost putrid. The fruit is also diuretic and is effective in the treatment of dropsy and 
renal stones. 
(2) The root is purgative and in high dose it can also serve as emetic.  
(3) The seed is demulcent, pectoral and tonic. It is sometimes used in the treatment of 
the urinary tract infections as well as bed wetting. The seed is also a good vermifuge 
and has a hypotensive action.  
(4) Preliminary research indicates that the consumption of watermelon may have 
antihypertensive effects  
(5) Fatty oil in the seed, as well as aqueous or alcoholic extracts have been reported to 
paralyze tapeworms and roundworms.  
(6) The rind of the fruit is prescribed in cases of alcoholic poisoning and diabetes  
(7) Citrullus lanatus is used in Northern Sudan for burns, swellings, rheumatism, gout 
and as laxative. 
(8) The fruits are used as a drastic purgative in Senegal; they are also used to treat 
diarrhoea and gonorrhoea in Nigeria. 
(9)  Tar is extracted from the seeds and used for the treatment of scabies and for skin 
tanning. The seed oil has an anthelmintic action which is better than that of pumpkin 
seed oil. 
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CHAPTER V 
PHARMACOGNOSTICAL STUDIES 
Pharmacognosy is the study of medicines derived from natural sources. The study of 
the physical, chemical, biochemical and biological properties of drugs, drug substances or 
potential drugs or drug substances of natural origin as well as the search for new drugs from 
natural sources is the definition given by The American Society of Pharmacognosy. It is the 
oldest of all pharmacy sciences. The name “Pharmacognosy was “derived from the Greek 
Pharmacon, a drug, and gignosco, acquire knowledge (the entire meaning of drugs). 
Pharmacognosy is related to both botany and plant chemistry “Phytochemistry “, and its 
history entitles it to be regarded as parent of both. [60,61] 
Fig: 1. Pharmacognosy is Parent for all 
 
At present pharmacognosy involves the study of crude drugs and their natural 
derivatives like Digitalis and its glycoside, digoxin; Datura and its alkaloid, atropine; Opium 
and its purified compound morphine.  
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Pharmacognostical evaluation represents valuable information regarding the 
morphology, microscopical and physical characters of crude drugs and thus gives the 
scientific information regarding the purity and quality of crude drugs. 
MATERIALS AND METHODS 
SECTION A - MACROSCOPICAL STUDIES [61- 66] 
 Macroscopical studies include aspects of the outward appearance (shape, structure, 
colour and pattern) as well as the form and structure of the internal parts like cells etc. Some 
of these gross morphological characters of drugs such as shape, size, margin, apex and 
venation are identification features of drugs. these features give valuable information about 
the drugs.  
Collection of plant material 
 The leaves of Citrullus lanatus have been collected in Thuvarankurichi during the 
month of August 2013. The plant was collected and authenticated by Dr. Stephen, Senior 
Lecturer in Botany and Taxonomist, American College, Madurai. The authenticated 
herbarium of plant has been kept in the Department of Pharmacognosy, Madurai Medical 
College, Madurai. A copy of herbarium is shown in Fig 2. 
The leaves of Citrullus lanatus were collected and the macroscopical characters like 
shape, structure, colour and pattern were studied. The photographic representations of the 
macroscopic features are presented in Figs 3. 
SECTION B - MICROSCOPICAL STUDIES [67-76] 
  Microscopical evaluation is indispensable in the initial identification of herbs, as 
well as in identifying small fragments of crude or powdered herbs, and in detection of 
  
Fig.2: Herbarium of Citrullus lanatus (Thunb.) Matsum. & Nakai. 
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adulterants (eg. insects, animal faeces, mould, fungi etc.) as well as identifying the plant by 
characteristic tissue features. Every plant possess a characteristic tissue structure, which can 
be demonstrated through study of tissue arrangement, cell walls, and configuration when 
properly mounted in stains, reagents and media.  
 The microscopical evaluation allows more detailed examination of the plant material 
to identify the organised drug by its histological character. It provides detailed information 
about the crude drugs by virtue of its property to magnify the fine structures of minute objects 
to be visualised and thereby confirm the structural details of the plant drugs under evaluation. 
It can also be used in the determination of the optical as well as micro chemical properties of 
the crude drug confirmation study. 
Collection of specimens 
 The plant specimen for the proposed study was collected from Citrullus lanatus leaf. 
Care was taken to select healthy plant. The leaf was cut and removed from the plant and fixed 
in FAA (Formalin- 5ml + Acetic acid- 5ml + 70% Ethyl alcohol-90 ml) After 24 hrs of 
fixing, the specimens were dehydrated with graded series of tertiary-Butyl alcohol as per the 
schedule given by Sass, 1940.[67] Infiltration of the specimens was carried by gradual addition 
of paraffin wax (melting point 58-60˚C) until TBA solution stained super saturation. The 
specimens were cast into paraffin blocks. 
Sectioning 
 The paraffin embedded specimens were sectioned with the help of Rotary 
Microtome. The thickness of the sections was 10-12µm. Dewaxing of the sections was by 
customary procedure (Johansen, 1940)[68]. The sections were stained with Toluidine blue as 
per the method published by O’Brien et al. (1964)[69]. Since Toluidine blue is a 
polychromatic stain. The staining results were remarkably good; and some cytochemical 
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reactions were also obtained. The dye rendered pink colour to the cellulose walls, blue to the 
lignified cells, dark green to suberin, violet to the mucilage, blue to the protein bodies etc. 
whenever necessary sections were also stained with safranin and Fast green and iodine in 
potassium iodide. 
  For studying the stomatal morphology, venation pattern and trichome distribution, 
paradermal sections (sections taken parallel to the surface of leaf) as well as clearing of leaf 
with 5% sodium hydroxide or epidermal peeling by partial maceration employing Jaffrey’s 
maceration fluid (Sass, 1940) were prepared. Glycerine mounted temporary preparations 
were made for macerated/cleared materials. Powdered materials of different parts were 
cleared with sodium hydroxide and mounted in glycerine medium after staining. Different 
cell component were studied and measured. 
Photomicrographs 
 Microscopic descriptions of tissues are supplemented with micrographs wherever 
necessary. Photographs of different magnifications were taken with Nikon labphoto 2 
microscopic Unit. For normal observations bright field was used for the study of crystals, 
starch grains, and lignified cells, polarized light was employed. Since these structures have 
birefringent property, under polarized light they appear bright against dark background. 
Magnifications of the figures are indicated by the scale-bars. Descriptive terms of the 
anatomical features are as given in the standard Anatomy books (Easu, 1964)[77]. The 
microscopic features observed for both plant are represented in Fig. 4 to 7. 
SECTION  C - QUANTITATIVE MICROSCOPY[76-78] 
 Quantitative analytical microscopy is useful in measuring the cell contents of the 
crude drugs and help in their identification, characterization and standardization. A clear idea 
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about the identity and characteristic features of the drug can be obtained after several 
numbers of determinations. The number so obtained can be compared with a standard value 
to find out whether it is within the range. It helps to determinine the purity of the plant 
material. 
LEAF CONSTANTS   
The stomatal number, stomatal index, vein islet number and vein termination number 
were determined on fresh leaves using the standard procedures. A number of leaf 
measurements are used to distinguish between some closely related species not easily 
characterised by general microscopy. 
Determination of stomatal number and stomatal index 
 Stomatal number: Stomatal number is the average number of stomata/sq.mm of 
epidermis of the leaf.  
Stomatal index: Stomatal index is the percentage which the number of stomata forms 
to the total number of epidermal cells. 
To study the morphology (type of stomata),stomatal number and stomatal index of leaf, the 
leaf was subjected to epidermal peeling. 
Procedure: The leaf was cleared by boiling with chloral hydrate solution. The upper 
and lower epidermis was peeled out separately by means of forceps. The cleared leaf was 
placed on the slide and mounted in glycerin. A camera Lucida and drawing board was placed 
and stage micrometer was inserted for making the drawing scale. A square of 1mm was 
drawn by means of stage micrometer. The slide with cleared leaf (epidermis) was placed on 
the stage of the microscope and examined under 45X objective and 10X eye piece. The 
epidermal cell and stomata was traced .The number of stomata present in the area of 1sq.mm 
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including the cell or   at least half of its area within the square was counted. The average 
number of stomata per sq.mm was determined and their values are tabulated. 
 For stomatal index, the glycerin mounted leaf peeling as mentioned above was made 
and circle like mark for each stomata and cross like mark for each epidermal cells was 
marked on the chart paper. The stomatal index was calculated by using the formula - 
Stomatal index I= S/ (E+S) X 100; where I is the stomatal index, S is the number of stomata 
in 1sq.mm area of leaf and E is the number of epidermal cells in 1sq.mm area of leaf. The 
values are tabulated. 
Determination of vein islet and vein termination number  
Vein islet number is defined as the number of vein islet per sq.mm of the leaf surface 
midway between the midrib and the margin. It is used to denote the minute area of 
photosynthetic tissue encircled by the ultimate division of the conducting strands. 
Vein termination number is defined as the number of vein termination per sq.mm of 
the leaf surface midway between the midrib and margin. A vein termination is the ultimate 
free termination of a veinlet or branch of a veinlet. 
Procedure: A few leaves were boiled in chloral hydrate solution in a test tube placed 
in a boiling water bath until clear. The cleared leaves were stained with saffranin solution and 
a temporary mount was prepared with glycerin solution. The stage micrometer placed on the 
microscopic stage, examined under 10X objective and 6X eye piece and an area of 1sq.mm 
square was drawn. The cleared leaf piece was placed on the microscope stage, the vein islets 
and vein terminals included in the square was drawn. The number of vein islets and vein 
terminals within the square were counted. The results obtained for the number of vein islets 
and vein terminals in 1sq.mm are tabulated in Table 1. 
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SECTION D - STANDARDIZATION PARAMETERS[77-80] 
 The determination of the foreign organic matter, loss on drying, ash values and 
extractive values etc. gives a clear idea about the specific characteristics of crude drug under 
examination, besides its macro-morphological or cyto-morphological, microscopical nature in 
both its entire and its powder form. These diagnostic features enable the analyst to know the 
nature and characteristic of crude drugs.  
FOREIGN ORGANIC MATTER 
 The part of organ or organs other than those specified in the definition or description 
of the crude drugs is defined as foreign organic matter. 
Procedure: 500g of the original sample was weighed and spread out in a thin layer and 
inspected with the unaided eye or with the use of a 6X lens and the foreign organic matter 
was separated manually as completely as possible. The foreign organic matter was weighed 
and the percentage of foreign organic matter was determined from the weight of the drug 
taken. The results obtained are presented in table 2. 
ASH VALUES  
The ash values for air dried powdered leaves of Citrullus lanatus were determined as 
per official method. The determination of ash is useful for detecting low grade products, 
exhausted drug and excess of sandy or earthy matter. 
Different types of ash values are used in detection of crude drugs like, total ash, acid 
insoluble ash, water soluble ash and sulphated ash.  
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Determination of total ash 
Total ash is useful in detecting the crude drugs that are mixed with various mineral 
substances like sand, soil, calcium oxalate, chalk powder or other drug with different 
inorganic contents to improve their appearance. 
Procedure: 2 to 3g of the air dried crude drug was weighed accurately and taken in a tared 
platinum or silica dish and incinerated at a temperature not exceeding 450oC until free from 
carbon then cooled and weighed. The percentage of ash with reference to the air dried drug 
was calculated.  The results obtained are presented in table 2. 
Determination of acid insoluble ash 
Acid insoluble ash is the residue obtained after boiling the total ash with dilute 
hydrochloric acid and igniting the remaining insoluble matter. This measures the amount of 
silica present, especially as sand and siliceous earth. 
Procedure  
 The ash obtained from the total ash was boiled for 5min with 25mL of 2M 
hydrochloric acid; the insoluble matter was collected in a Gooch crucible or on an ashless 
filter paper and washed with hot water and ignited, cooled in a dessicator and weighed. The 
percentage of acid insoluble ash was calculated with reference to the air dried drug. The 
results obtained are presented in table 2. 
Determination of water soluble ash 
Water soluble ash is used to detect the presence of material exhausted by water. If 
carbon is still present after heating at a moderate temperature, the water- soluble ash may be 
separated and the residue again ignited. 
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Procedure   
 The ash obtained from the total ash was boiled for 5min with 25mL of water; the 
insoluble matter was collected in a Gooch crucible or on an ashless filter paper and washed 
with hot water and ignited for 15min at a temperature not exceeding 450oC.  The weight of 
the insoluble matter was subtracted from the weight of the total ash; the difference in weight 
representing the water soluble ash. The percentage of water soluble ash was calculated with 
reference to the air dried drug. The results obtained are presented in table 2. 
Determination of sulphated ash  
The treatment of the drug with sulphuric acid before ignition, whereby all oxides and 
carbonates are converted to sulphates is called as sulphated ash.  
Procedure  
 A platinum dish was heated to redness for 10min and allowed to cool in a desiccator 
and weighed. 1g of the substance being examined was placed in the dish, moistened with 
sulphuric acid, ignited gently, moistened again with sulphuric acid and ignited at about 
800°C. It was then cooled and weighed. The percentage of sulphated ash was calculated with 
reference to the air dried drug. The results obtained are presented in table 2. 
LOSS ON DRYING  
The moisture content of a drug should be minimized to prevent decomposition of 
plant material due to chemical or microbial contamination. It may be determined by heating a 
material at constant temperature to constant weight.  
Procedure  
 About 2g of the powdered crude drug was accurately weighted in a tared dish and 
dried in an oven at 100˚-105˚ C. It was cooled in a desiccator and again weighed. The loss on 
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drying was calculated with reference to the amount of the dried powder taken and the results 
obtained are presented in table 2.  
EXTRACTIVE VALUES  
The extractive values are the important factor to determine the amount of active 
principle or phytoconstituents present in the plant materials, when extracted with suitable 
solvents. The extraction of crude drug with a particular solvent yields a solution containing 
different phyto-constituents. The composition of these phyto constituents in that particular 
solvent depends upon the nature of the drug and solvent used. The use of a single solvent can 
be the means of providing preliminary information on the quality of a particular drug sample; 
for example, in a drug where the extraction procedure for the constituents commences with 
water as the solvent, any subsequent aqueous extraction on the re-dried residue will give a 
very low yield of soluble matter. 
Determination of water soluble extractive 
Procedure: 5g of the air dried drug, coarsely powdered have to be macerated with 
100mL of water closed flask for 24h, shaking frequently during the first 6h and allowing to 
stand for 18h. Thereafter, filter rapidly taking precautions against loss of water, evaporate 25 
mL of the filtrate to dryness in a tared flat-bottomed shallow dish, dry at 105°C and weigh. 
The percentage of water soluble extractive with reference to the air dried drug was calculated. 
Determination of ethanol soluble extractive 
Procedure  
Macerate 5g of the air dried drug, coarsely powdered, with 100mL of the ethanol of 
the specified strength in a closed flask for 24h, shaking frequently during the first 6h and 
allowing to stand for 18h. Thereafter, filter rapidly taking precaution against ethanol, 
evaporate 25mL of the filtrate to dryness in a tared flat-bottomed shallow dish, dry at 105°C 
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and weigh. Calculate the percentage of ethanol soluble extractive with reference to the air 
dried drug. 
Determination of ethanol soluble extractive 
Procedure  
 Macerate 5g of the air dried drug, coarsely powdered, with 100mL of the methanol of 
the specified strength in a closed flask for 24h, shaking frequently during the first 6 hours and 
allowing to stand for 18h. Thereafter, filter rapidly taking precaution against ethanol, 
evaporate 25mL of the filtrate to dryness in a tared flat-bottomed shallow dish, dry at 105°C 
and weigh. Calculate the percentage of methanol soluble extractive with reference to the air 
dried drug. 
Determination of petroleum ether soluble extractive 
The procedure adopted under ethanol soluble extractive was followed using petroleum 
ether as a solvent. 
Determination of hexane soluble extractive 
The procedure adopted under ethanol soluble extractive was followed using hexane as 
a solvent. 
Determination of chloroform, benzene, ethyl acetate and acetone soluble extractive 
The procedure adopted under ethanol soluble extractive was followed using the 
requisite solvent as the medium of extraction.The results obtained for the various extractive 
values are presented in table 2. 
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FOAMING INDEX  
Some plant materials when shaken with water cause persistent foam which may be 
attributed to the presence of saponins in that material. The foaming ability of an aqueous 
solution of plant materials and their extracts is measured in terms of foaming index.  
Procedure  
An accurate quantity of about 1g of the coarse plant material was weighed and 
transferred into an Erlenmeyer flask containing 100mL of boiling water. The flask was boiled 
at moderate heat for 30min. The solution was cooled and filtered into a 100mL volumetric 
flask and sufficient distilled water was added to dilute to volume. The solution was poured 
into ten stoppered test tubes in successive portions of 1mL, 2mL, etc. upto 10mL, and the 
volume of the liquid in each tube was adjusted with water upto 10mL. The tubes were then 
stoppered and shaken in a length wise motion for 15sec (two shakes/sec) and allowed to stand 
for 15min. The height of foam was measured.  If the height of the foam in every tube was less 
than 1cm the foaming index was less than 100. If a height of foam of 1cm was measured in 
any test tube, the volume of the plant material decoction in this tube (a) was used to 
determine the index.  If the height of the foam was more than 1cm in every tube, the foaming 
index was over 1000. In this case, the determination was repeated using a new series dilution 
of the decoction in order to obtain a result. The foaming index was calculated by using the 
following formula 1000/A where A was the volume in mL of the decoction used for 
preparing the dilution in the tube where foaming to a height of 1cm was observed. The results 
obtained are presented in table 2. 
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SWELLING INDEX  
            Swelling index is the volume in mL taken up by the swelling of plant material under 
specified conditions. The medicinal plant materials like gums, mucilage, and pectin have 
swelling property. 
             Procedure: An accurately weighed 1g of the powdered drug material was taken in 
the 25mL glass stoppered measuring cylinder. 25mL of water was added and shaken the 
mixture thoroughly every 10min for 1h. Then, allowed to stand for 3h at room temperature. 
The volume in mL occupied by the plant material was measured, including sticky mucilage 
was observed. The results obtained are presented in table 2.  
SECTION E - POWDER ANALYSIS & MICROSCOPY[81-83] 
            The powdered crude drug analysis was aimed to study and also to assess the quality of 
herbal drugs for therapeutic value which are generally studied by classical pharmacognostical 
studies. The authenticity of herbal drugs was confirmed by comparison of their powder 
characteristics. 
Procedure 
A) Reaction of chemicals with powdered crude drugs 
            The raw leaf powder of Citrullus lanatus was treated with different chemical     
reagent such as iodine solution, 10% potassium hydroxide solution, glacial acetic acid etc. on 
a clean watch glass for the identification of secondary metabolites. The colours obtained with 
various reagents are presented in Table 3. 
B) Fluorescence analysis 
             The fluorescence nature of powder drugs was analysed to find out whether any 
fluorescent compound was present in the sample and the observations with different 
chemicals were also carried out and recorded. The air dried plant materials of both plants 
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were taken in clean warch glass and subjected to different chemicals such as acids, alkalis 
and some reagents are observed under day light and UV light. Detailed fluorescence behavior 
of crude drug powder has been shown in Table 4. 
C)  Powder microscopy 
           The dried leaf was powdered and the powder was passed through sieve no.60 for the 
study of powder microscopy. Chloral hydrate, water, iodine, phloroglucinol and hydrochloric 
acid (1:1) etc. were employed as mounting medium. The pictorial representation are 
presented in Fig 8. 
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RESULTS AND DISCUSSION 
SECTION A - MACROSCOPICAL EVALUATION 
Macroscopical characters of Citrullus lanatus (Thunb.) Matsum. & Nakai 
Whole plant: Citrullus lanatus is an annual climbing or trailing herb, with hairy stem up to 
10 m long. Tendrils divided at the tip into two or three parts. Separate male and female 
flowers are borne on the same plant. (Fig. 3.1) 
Leaves: Leaf blades up to about 20 × 20 cm, more or less hairy, usually deeply 3–5-lobed, 
the central lobe being the largest. The lobes themselves are further divided. Leaf stalks 
(petioles) up to about 19 cm long, more or less hairy. (Fig. 3.2, 6, 7) 
Flowers: Solitary, borne in leaf axils. Both male and female flowers are yellow, up to 3 cm in 
diameter, and borne on pedicels (flower stalks) up to 45 mm long. Flowers are usually 
pollinated by honey bees. (Fig. 3.3) 
Fruits: Fruits of wild plants up to about 20 cm in diameter, greenish mottled with darker 
green. Fruits of cultivated plants up to about 70 × 30 cm, rounded, oval or oblong, with a 
golden-yellow to dark green skin, the skin being uniform, mottled or striped. Flesh usually 
red or yellow, sometimes orange, pink or white. (Fig.3.4) 
Seeds: Flat, smooth, variable in size and colour (white, tan, brown, black, red, green or 
mottled).(Fig. 3.5) 
SECTION B - MICROSCOPICAL EVALUATION 
Anatomy of the leaf: The leaf has very thick abaxially hanging midrib and thin lamina 
(Fig.4.1). The midrib is 1.9mm thick and 1.7mm wide. It has four thick ridges alternatively 
deep furrows. (Fig.4.1) The adaxial part of the midrib has short, tick cone. The epidermis has 
                                  
                                   Fig. 3.1. HABITAT AND WHOLE PLANT OF  
                                       Citrullus lanatus (Thunb.) Matsum. & Nakai 
 
                    
 
                  
                       Fig. 3.2. LEAF OF Citrullus lanatus (Thunb.) Matsum. & Nakai 
 
                     
 
      Fig. 3.3. FLOWER OF Citrullus lanatus (Thunb.) Matsum. & Nakai 
      
         
 Fig. 3.4. FRUITS OF Citrullus lanatus (Thunb.) Matsum. & Nakai     
 
         
 
 
                 Fig. 3.5. SEEDS OF Citrullus lanatus (Thunb.) Matsum. & Nakai 
                          
 
                            
    Fig. 3.6. DORSAL VIEW OF Citrullus lanatus (Thunb.) Matsum. & Nakai LEAF. 
 
 
  Fig. 3.7. VENTRAL VIEW OF Citrullus lanatus (Thunb.) Matsum. & Nakai LEAF.
 
      
   Fig. 3.8. LINE DRAWING OF Citrullus lanatus (Thunb.) Matsum. & Nakai. 
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thin intact epidermal layer of rectangular cells. Inner to the epidermis is a narrow, two or 
three layers of collenchyma and the remaining ground tissue is thin walled compact 
parenchyma cells. 
           The vascular system of the midrib is multi stranded. There is a large abaxial median 
bundle, two adaxial lateral smaller bundles and cone still smaller adaxial median bundles 
(Fig. 4.1) All the bundles are bicollateral having phloem strands both on the outer and inner 
sides of the xylem. The xylem consists of short radial chains of wide circular elements. 
Phloem strands are composed of small groups of sieve elements which are small and darkly 
stained. (Fig.4.2, 3). 
            The lateral vein is simple in structure. It projects slightly on the lower side and the 
upper side is flat. (Fig. 5.1) The epidermal cells of the lateral veins are large and thick; they 
are circular or cylindrical and thin walled. The vascular bundle is small, collateral and 
includes adaxial group of angular xylem elements and small cluster of abaxial phloem 
elements. 
Lamina (Fig. 5.2): The lamina is 90-100µm thick. It is heterofacial with distinct adaxial 
sides. It is heterofacial with distinct adaxial and abaxial side. It is amphistomatic with stomata 
located on the adaxial and abaxial side.The epidermal cells are small elliptical or rectangular 
and thin walled. The palisade zone consists of single layer of cylindrical cells which are 
loosely arranged. The sponge parenchyma cells small and spherical. They form wide air 
chambers separated by partition filaments. (Fig. 5.2) 
Stomata (Fig.6.1, 2, 3): The stomata epidermal cells were studied in paradermal sections of 
the lamina. The epidermal cells small and vary in shape and size. Their anticlinal walls are 
thick and wavy. The stomata are diffuse in distribution. (Fig.6.1,2) The stomatal type is 
actinocytic. (Fig.6.2, 3)  The stoma is surrounded by three to six subsidiary cells which 
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radiate from the guard cells. (Fig.6.2,3) The guard cells are broadly elliptical and are 
15x20µm in size. 
Venation pattern (Fig.7.1,2): The venation is reticulate type. The reticulation is dense. The 
veins are thin and straight. The vein-islets are distinct and are surrounded by thin and straight 
veins. The vein terminations are either triple (unbranched) or branched forming tree like 
outline. (Fig7.2.). Multi cellular, uniseriate unbranched epidermal trichomes are occasionally 
seen on the epidermis. The trichome has spherical terminal cells. The trichome is 450µm 
long.                                       
                  SECTION C -QUANTITATIVE ANALYTICAL MICROSCOPY 
The results obtained for the determination of leaf constants are presented in Table.1.  
Table.1 : Quantitative analytical microscopical parameters of the leaf of Citrullus 
lanatus 
S.  
No. 
Parameters* Values 
obtained 
1 Stomatal number in upper epidermis 21.83 ± 0.300 
2 Stomatal number in lower epidermis 32.25 ± 0.629 
3 Stomatal index in upper epidermis 19.68 ± 0.396 
4 Stomatal index in lower  epidermis 22.12 ± 0.093 
5 Vein islet number 12.66 ± 0.333 
6 Vein termination number 19.66 ± 0.881 
                          *mean of three readings ± SEM 
From the table, it can be observed that the number of stomata in the upper epidermis 
was found to be 21.83 ± 0.300 while in the lower epidermis it was 32.25 ± 0.629. The 
stomatal index in upper epidermis and lower epidermis was 19.68 ± 0.396 and 22.12 ± 0.093 
respectively. The vein islet number was found to be 12.66 ± 0.333 and the vein termination 
number was 19.66 ± 0.881. The values help in identification of leaf of Citrullus lanatus from 
the species of the genus Citrullus since these values are unique for each plant. 
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SECTION D - STANDARDIZATION PARAMETERS 
The results obtained for various standardization parameters are presented in Table 2. 
From the table 2, it can be seen that the foreign organic matter present in the crude material 
was very low. The percentage of total ash was found to be 14.73 ± 0.080 and the percentage 
of water soluble ash was found to be 4.03 ± 0.062 while the acid insoluble ash was 1.28 ± 
0.074 and the percentage of sulphated ash was found to be 17.76 ± 0.292. The determination 
of ash values helps to find out where the powdered material was adulterated with sand and 
other inorganic material. The water soluble ash helps us to find the amount of inorganic 
material present in the crude drug, while acid insoluble ash helps us to find the amount of 
sand and other debris in the crude material. 
The various extractive values with different solvents have been determined. A 
maximum extractive value was found with methanol (26.57 ± 0.268) followed by water 
(24.99 ± 0.671). The extractive values helps us to decide what solvent will be useful for 
extraction of maximum active principle and also helps to decide whether the crude material 
has already been exhausted or not. 
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Table.2 : Standardization parameters of Citrullus lanatus 
 
S. No Parameters* Values* expressed as % 
1 Foreign organic matter   0.04 ± 0.180 
2 Loss on drying   7.29 ± 0.012 
3 Ash value  
 Total ash 14.73 ± 0.080 
 Acid insoluble ash   1.28 ± 0.074 
 Water soluble ash   4.03 ± 0.062 
 Sulphated ash 17.76 ± 0.292 
4 Extractive values  
 Petroleum ether 29.33 ± 0.360 
 Chloroform   7.39 ± 0.101 
 Ethyl acetate   8.09 ± 0.210 
 Ethanol 13.65 ± 0.413 
 Methanol 26.57 ± 0.268 
 Water 24.99 ± 0.671 
 Acetone 11.25 ± 0.145 
 Benzene   5.87 ± 0.153 
 Hexane   5.64 ± 0.046 
5 Foaming index         <100 
6 Swelling index  2.4 ± 0.493(ml) 
*mean of three readings ± SEM 
The pharmacognostic evaluation which includes macroscopical, microscopical, 
analytical parameter evaluation helps in identity, quality and purity of the plant material 
either as a whole or in the form of powder. 
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SECTION E - POWDER ANALYSIS & MICROSCOPY 
The powdered crude drug analysis was aimed to study and also to assess the quality of 
herbal drugs for therapeutic value which are generally studied by classical pharmacognostical 
studies. The authenticity of herbal drug was confirmed by comparison of their powder 
characterics. The reaction of various chemical reagents is tabulated in Table 3. 
Table 3: Reaction of chemical with powdered drug Ctrullus lanatus 
with various chemical reagents 
Drug powder + reagent 
Colour 
in day light (Visible) 
Colour in UV light 
254nm 365nm 
Powder  Yellowish green Dark green Yellowish green 
Powder + 1M sodium 
hydroxide  
Yellowish green 
Fluorescent 
green 
Dark green 
Powder + Iodine  Yellowish green Dark green Dark brown 
Powder + 10% potassium 
hydroxide 
Yellow 
Fluorescent 
green 
Dark brown 
Powder + 1M 
hydrochloric acid 
Yellowish brown Dark green Dark brown 
Powder + Glacial acetic 
acid 
Yellowish green Green Orange 
Powder + 50% sulphuric 
acid 
Yellowish green Dark green Dark brown 
Powder + 50% nitric acid  Brown Greenish  Dark brown 
Powder + 50% 
Hydrochloric acid 
Yellowish brown Dark green Dark brown 
Note :  Colour reactions are viewed under natural light by naked eye 
 From the table, it can be observed that the powder with 10% potassium hydroxide and 
1M sodium hydroxide under UV light at 254nm exhibited a fluorescent green which will be 
useful for identification of the plant material in crude form. 
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Fluorescent analysis of the Extracts 
The behavior of various extracts in natural light and under UV light at 254nm and 
365nmand presented in Table.4  
 From the table, it was observed that the ethanolic, methanolic, chloroform, benzene, 
petroleum ether, ethyl acetate, water, acetone and hexane extracts were orange colour under 
UV light at 365nm. The petroleum ether and water extracts were fluorescent green colour 
under UV light at 365nm. These parameters are useful for quality control and purity checking 
of the plant in powder form. 
Table 4 : Fluorescence analysis of extracts of Citrullus lanatus 
Extract Consistency
Colour in day light 
(Visible) 
Colour in UV light 
254nm 365nm 
Ethanol Semisolid Light green Dark green Orange 
Methanol Semisolid Yellowish green Dark green Light orange 
Benzene Semisolid Yellowish green Dark green Dark orange 
Petroleum ether Semisolid Light yellow Dark green Fluorescent green 
Ethyl acetate Semisolid Light green  Dark green Dark orange 
Water Semisolid Yellowish green Greenish black Fluorescent green 
Chloroform Semisolid Light green Green Dark orange 
Acetone Semisolid Light green Green Dark orange 
Hexane Semisolid Light green Dark green  Orange  
 
Powder microscopy 
           The various characteristic features observed when seen under a microscope are 
presented in Fig. 8. The features observed under a microscope include stomata, unbranched 
trichomes, xylem and phloem vessels. 
Fig.8.: Powder Microscopy of Citrullus lanatus (Thunb.) Matsum. & Nakai 
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CHAPTER VI 
PHYTOCHEMICAL EVALUATION 
Phytochemicals means plant chemicals. They are naturally occuring in plants. They 
give plants its colour, flavour, smell and are part of a plant’s natural defence system (disease 
resistance). The phytochemicals are bioactive, non-nutrient plant compounds in fruits, 
vegetables, grains and other plant foods that have been linked to reducing the risk of major 
degenerative diseases. [84] 
In plants phytochemicals attract beneficial and repel harmful organisms, serve as 
photoprotectants, and respond to environmental changes. They work together with nutrients 
and dietary fibres to protect the body against diseases, slow the aging process and reduce the 
risk of many diseases such as cancer, heart disease, stroke, high blood pressure, cataracts, 
osteoporosis and urinary tract infection. Alkaloids have analgesic effects,  glycosides are used 
in cardiac diseases, tannins prevent urinary tract infection by preventing bacteria from 
adhering to the walls. Tannins, along with vitamin C help build and strengthen collagen. 
Saponins serve as natural antibiotics, which help body to fight infections and microbial 
invasions. They also enhance the effectiveness of certain vaccines, lower cholesterol and 
knock out some tumor cells. Flavonoids have antioxidant activity in biological systems and 
protect the body against allergies, inflammation, free radicals, platelet aggregation, microbes, 
ulcers, hepatoxins, viruses and tumors The flavonoid quercetin is known for its ability to 
relieve hey fever, eszema, sinusitis and asthma while certain flavonoids also can protect low-
density-lipoproteins from being oxidized, thereby playing an important role in 
atherosclerosis.[85] 
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MATERIALS AND METHODS 
COLLECTION AND PREPARATION OF EXTRACT 
The leaves of Citrullus lanatus were collected in Thuvarankurichi during the month of 
August 2013. The leaves were washed thoroughly and dried in shade. The shade dried leaves 
were powdered and used for further studies.  
Extraction of leaves of Citrullus lanatus was carried out by washing the plants and 
drying at room temperature in 14 days. After that, they were filtered with sieve analyzer to 
get homogeneous particles and defatted with 2.5L of petroleum ether (60-80˚C) by cold 
maceration method for 72h. The solvent was then removed by filtration and the marc was 
dried. The dried marc was re-soaked with 2.5L of methanol. The steps were performed three 
times and the combined filtrates were evaporated to a cohesive mass using rota vapour. 
SECTION A - PRELIMINARY PHYTOCHEMICAL SCREENING [86-90] 
             The preliminary phytochemical screening helps us in identifying the type of 
secondary metabolites present in plants. The screening was carried out Aqueous and 
methanolic extract of citrullus lanatus leaf powder. The various chemical tests carried out are 
described. 
1. Test for carbohydrates 
a. Molisch’s Test: The aqueous extract of the powdered leaf when treated with 
alcoholic solution of α-naphthol in the presence of sulphuric acid. Purple colour indicates the 
presence of carbohydrates. 
b.   Benedict’s test: The aqueous extract of the powdered was treated with Benedict’s 
reagent and boiled on water bath and cooled. An orange colour precipitate indicates the 
presence of carbohydrates. 
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c. Fehling’s Test: The aqueous extract of the powdered leaf was treated with 
Fehling’s solution I and II and heated on a boiling water bath for half an hour. A red 
precipitate indicates the presence of free reducing sugars. 
2. Test for Alkaloids 
About 2g of the powdered material was mixed with 1g of calcium hydroxide and 5mL 
of water into a smooth paste and set aside for 5min. It was then evaporated to dryness in a 
porcelain dish on a water bath. To the residue, 20mL of chloroform was added, mixed well 
and refluxed for half an hour on a water bath. Then it was filtered and the chloroform was 
evaporated. To the residue, 5mL of dilute hydrochloric acid was added. The solution was 
divided into four parts and 2mL of each of the following reagents were added and the colour 
noted below indicates the presence of alkaloids. 
a) Mayer’s Reagent  -     Cream precipitate  
b) Dragendorff’s Reagent  -      Reddish brown precipitate  
c) Hager’s Reagent  -     Yellow precipitate 
d) Wagner’s Reagent  -      Reddish brown precipitate 
3. Test for phytosterols 
The powdered leaf was first extracted with petroleum ether and evaporated to a 
residue. Then the residue was dissolved in chloroform and tested for phytosterols. 
a.  Salkowski’s Test: A few drops of concentrated sulphuric acid were added to the 
above solution, shaken well and set aside. The lower chloroform layer of the solution turning  
red indicates the presence of phytosterols. 
b. Liebermann – Burchard’s Test: To the chloroform solution a few drops of acetic 
anhydride and 1mL of concentrated sulphuric acid were added through the sides of the test 
tube and set aside for a while. At the junction of two layers a brown ring and the upper layer 
turning green indicates the presence of phytosterols. 
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4. Test for glycosides  
The substance was mixed with a little anthrone on a watch glass. One drop of 
concentrated sulphuric acid was added, made into a paste and warmed gently over a water 
bath. A dark green coloration indicates the presence of glycosides. 
 Test for Cardiac Glycosides 
a. Keller Killiani Test: The substance was boiled with 10% alcohol for 2min, cooled 
and filtered. To the filtrate, lead sub acetate was added and filtered. The filtrate was then 
extracted with chloroform. The chloroform layer was separated and evaporated to dryness. 
The residue was dissolved in glacial acetic acid with traces of ferric chloride. To this few 
drops of sulphuric acid was added slowly along the sides of the test tube. A reddish brown 
layer changes to green colour on standing.  
b. Legal test: The substance was dissolved in pyridine, sodium nitroprusside solution 
was added to it and made alkaline. A pink or red colour indicates the presence of cardiac 
glycosides. 
c. Baljet test: To the substance sodium picrate solution is added. A yellow to orange 
colour indicates the presence of cardiac glycosides. 
5.  Test for Proteins and free amino acids 
a. Millon’s Test: A small quantity of acidulous-methanolic extract of the powdered 
drug was heated with Millon’s reagent. A white precipitate turning red on heating indicates 
the presence of proteins.  
b. Biuret Test: To the methanolic extract of powdered drug, one ml of dilute sodium 
hydroxide(10%) solution was added followed by this one drop of very dilute copper sulphate 
solution was added. A violet colour indicates the presence of proteins. 
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c. Ninhydrin test: To the methanolic extract of powdered drug, two drops of 
ninhudrin solution (10mg of ninhydrin in 200mL of acetone) were added to 2mL of aqueous 
filtrate. A characteristic purple colour indicated the presence of amino acid. 
6. Test for Mucilage 
A few mL of aqueous extract was prepared from the powdered drug was treated with 
ruthenium red. Pinkish red colour indicates the presence of mucilage. 
7. Test for Flavonoids 
a. Magnesium turning- con HCl test:  A little of the powdered drug was heated with 
alcohol and filtered. To the test solution magnesium turnings and few drops of concentrated 
hydrochloric acid were added and Boiled for five minutes. A red colour indicates the 
presence of flavonoids. 
 b.   Alkali Test: To the small quantity of test solution 10% aqueous sodium 
hydroxide Solution was added. A yellow orange color indicates the presence of flavonoids.  
 c. Acid Test: To a small quantity of test solution, few drops of concentrated sulphuric 
acid was added. A yellow orange color indicates the presence of flavonols. 
8. Test for terpenoids 
The powdered leaf was shaken with petroleum ether and filtered. The filtrate was 
evaporated and residue obtained was dissolved in small amount of chloroform and the 
chloroform solution tin and thionyl chloride were added. A pink color indicates the presence 
of terpenoids. 
9. Test for phenolic compounds 
           Small quantity of powdered sample was tested with the following reagents and the 
colour produced indicates the presence of phenolic compounds.  
a. 5% Ferric chloride solution  ---   Deep bluish black colour. 
b. Lead acetate solution           ---   White precipitate. 
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c. Bromine water                      ---   Decolouration of bromine water. 
d. Acetic acid solution               ---   Red colour. 
e. Dilute iodine solution           ---   Transient red colour. 
f. Tannic acid                              ---   Precipitate. 
10. Test for Tannins            
A small quantity of the powdered drug was extracted with water. To the aqueous 
extract, few drops of ferric chloride solution were added. A bluish black color indicates the 
presence of tannins. 
11. Test for saponins 
           About 0.5g of the powdered drug was boiled gently for 2min with 20mL of water and 
filtered while hot and allowed to cool. 5mL of the filtrate was then diluted with water and 
shaken vigorously.  A frothing indicates the presence of saponins. 
12.  Test for volatile oil 
           About 250gm of fresh leaves of Citrullus lanatus was weighed and subjected to 
hydrodistillation separately using volatile oil estimation apparatus (BP 1980). Absence of 
volatile oil. 
The above chemical tests were carried out on aqueous and methanolic extract of 
Citrullus lanatus leaf powder and the results were tabulated in Table 5. 
SECTION B - QUANTITATIVE ESTIMATION OF PHYTOCONSTITUENTS 
               Phytochemical constituents such as tannins, flavonoids, phenols, alkaloids and 
several other aromatic compounds or secondary metabolites of plants serve as a defence 
mechanism against predation by many microorganism, insects and herbivores. The curative 
properties of medicinal plants are perhaps due to the presence of these secondary metabolites 
Medicinal plants may be used to cure some common and other various diseases.[91] 
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Estimation of total phenol content [92-93] 
Natural bioactive compounds like phenols and flavonoids are important secondary 
metabolites in plants having intrinsic properties that affect appearance, taste, odour and 
oxidative stability of plant based foods. These compounds also posses biological properties 
like antioxidant, anti-aging, anti-carcinogen, protection from cardiovascular, immune and 
autoimmune diseases and brain dysfunctions viz. Parkinson’s, Alzheimer’s, Huntington’s 
diseases, etc  
Principle [94-98] 
             The total phenolic content of methanolic extracts of Citrullus lanatus were 
determined by Folin Ciocalteu reagent method. All the phenolic compounds are oxidized by 
the Folin-Ciocalteu Reagent and the reaction was neutralized with sodium carbonate, which 
is reduced during oxidation of the phenolic substances, into a mixture of blue molybdenum 
and tungsten oxides. The blue colour produced has a maximum absorption at about 760nm. 
The absorption is proportional to the quantity of oxidized phenolic compounds. The 
absorbance of the resulting blue colour was measured at 760nm, using gallic acid as standard. 
Instrument 
          Shimadzu UV Visible spectrophotometer, Model 1800 
Reagents   
a) Folin Ciocalteu Reagent (1N) 
Commercially available Folin Ciocalteu Reagent (2N) was diluted with an equal 
volume of distilled water. The resultant solution was kept in a brown   color bottle and 
stored in refrigerator at 4ºC. 
b)  Sodium carbonate solution (10%) 
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Procedure 
           Gallic acid was accurately weighed and diluted in water to concentration of 1mg/mL.  
This solution was suitably diluted to get concentrations ranging from 2, 4, 6, 8, 10µg/mL. 
0.5mL of Folin Ciocalteu reagent was added and allowed to stand for 15min. Then 1mL of 
10% sodium carbonate solution was added. Finally the mixtures were mixed with distilled 
water and made upto10mL, allowed to stand for 30min at room temperature and total phenols 
were determined by spectrophotometrically at 760nm using the reagent as blank. 
The methanolic extract of Citrullus lanatus was weighed and diluted to get a solution 
of 1mg/mL. Different concentrations of the solution were taken in separate test tubes. 0.5mL 
of Folin Ciocalteu reagent was added and allowed to stand for 15min. Then 1mL of 10% 
sodium carbonate solution was added. Finally the mixtures were mixed with distilled water 
and made upto10mL, allowed to stand for 30min at room temperature and total phenols were 
determined by spectrophotometrically at 760nm using the reagent as blank. 
             A calibration curve was generated by plotting concentration of gallic acid versus 
absorbance (Fig.9). A linear regression equation was determined using regression analysis. 
The total phenol content was calculated using the linear regression equation and expressed in 
terms mg of gallic acid equivalent per gm of extract (mg GAE/g). The results obtained are 
presented in Table 6. 
Estimation of total flavonoids content [99-101] 
Principle 
The aluminum chloride colorimetric technique was used for estimation of total 
flavonoid estimation .Aluminum ions form stable complexes with C4 keto group and either to 
C3 or C5 hydroxyl groups of flavones and flavonols in acidic medium. It also forms acid 
labile complexes with ortho hydroxyl groups in the A or B rings of flavonoids. These 
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complexes showed a strong absorption at 415nm which is used for the estimation of 
flavonoids.  
Instrument 
            Shimadzu UV Visible spectrophotometer, Model 1800 
Reagents  
10% aluminum chloride 
1M potassium acetate 
Procedure 
An aliquot quantity of quercetin was dissolved in ethanol to get a stock solution of 
1mg/mL. Further dilutions were made to get concentrations ranging from 20-100µg/mL. 1mL 
of the above standard solutions were taken in different volumetric flasks, 0.1mL of aluminum 
chloride solution, 0.1mL of potassium acetate solution and 2.8mL of ethanol were added and 
the final volume was then made up to 5mL with distilled water. After 20min the absorbance 
was measured at 415nm. A sample without aluminium chloride was used as a blank. From 
the absorbance obtained, a calibration curve was constructed by plotting concentration versus 
absorbance of quercetin (Fig.10). 1mL of methanolic extract at concentrations 50µg/mL and 
100µg/mL were taken and the reaction was carried out as above and the absorbance was 
measured at 415nm after 20min and the readings were tabulated in Table 7. The amount of 
flavonoids present can be determined by linear regression analysis. The total flavonoid 
content was expressed as mg querecetin equivalents /g of extract. 
Estimation of total tannin content [102-103] 
                Tannins are naturally occurring polyphenolic compounds of varying structure. 
Tannins are having antioxidant and microbial activities and also used as antiseptic and 
astringents. They are divided into two main groups namely hydrolysable and condensed. 
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Hydrolysable and tannins contain a polyhydric alcohol and condensed tannins are mostly 
flavonols. 
Principle  
The tannins are estimated by Folin-Denis Method. This is based on the non 
stoichiometric oxidation of the molecules containing a phenolic hydroxyl group. Tannins 
reduce phosphotungstomolybdic acid in alkaline solution to produce a highly colored blue 
solution. The intensity is directly proportional to the amount of tannins and measured in a 
spectrophotometer at 700nm. 
Instrument  
                 Shimadzu UV Visible spectrophotometer, Model 1800 
Reagents 
                 Folin-Denis reagent 
                10% Sodium carbonate solution 
Procedure 
About 0.2mL of methanolic extract of C. lanatus was pipetted into test tubes. To this, 
0.5ml of Folin-Denis reagent and 0.8mL of distilled water was added. The tubes were kept 
aside for 15min. To this, 1mL of sodium carbonate solution was added and the remaining 
volume was made up with 7.5mL of distilled water. Then the tubes were shaken and the 
absorbance was recorded at 700nm after 30min. Tannic acid, used as a standard was taken  at 
different concentration i.e 2, 4, 8, 12, 16, 20µg/mL in different test tubes and the procedure 
adopted above was followed. The calibration curve for tannic acid was plotted using 
concentration versus absorbance (Fig.11).  A linear regression equation was calculated and 
the equation was used to calculate the amount of total tannins as tannic acid equivalent. The 
amount of tannin content is expressed in mg/g of extract. The results obtained are presented 
in table 8. 
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Estimation of  vitamins[104-108] 
Nutrients are building blocks of the human body that regulate essential body functions 
as well as furnish them with the energy for their work. Nutrients are divided into macro-
nutrients (proteins, fats, carbohydrates) and micronutrients (vitamins and minerals).  
Vitamins are class of micro nutrients which play an essential role in human health and 
are classified into water soluble (niacin, riboflavin, and thiamine) and fat soluble (retinol and 
tocopherol). Plants synthesize most of the vitamins and serve as primary sources of these 
dietary essentials.   
Riboflavin is involved in the regulatory functions of some hormones that are 
connected with carbohydrate metabolism.  
Niacin (Vitamin B3) is essential for the normal functioning of the skin, intestinal tract 
and the nervous system.  
Tocopherol as a lipophilic vitamin is the most powerful antioxidant. Tocopherol 
protects the red blood cell from hemolysis, boosts the immune response, and reduces the risk 
of myocardial infarction by reducing the oxidation of LDL as well  as acting as an anti-
mutagen. It also functions synergistically with other antioxidants like vitamin A and C and 
selenium. 
 Vitamin C functions as a water soluble antioxidant.  
Carotenoids are antioxidant compounds found in plants that can enhance the human 
health immune response by playing preventive roles against degenerative diseases such as: 
cancer, carcinogenesis and cardiovascular diseases, vision related abnormalities, 
Parkinsonism, infertility, etc. This source of vitamin A from vegetables and fruits is the main 
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source for people living in developing countries and makes up about 70-90% of their dietary 
Vitamin A intake. 
The composition of the water-insoluble vitamins, riboflavin and thiamine were 
determined by the method of Okwu, D.E and C.Joshi, and ascorbic acid content was 
determined by the method of Sarojini et al. 
Estimation of vitamin B1  [109-112] 
Principle 
The estimation of Vitamin B1 was carried out using the method of Okwu, D.E and C. 
Joshi with slight modification. The reaction of thiamine hydrochloride with potassium 
dichromate (K2Cr2O7) has been studied in alcoholic solution at room temperature. The 
compound obtained is ionic 1:1 in which thiamine is present as a cation and Cr2O72- as an 
anion. The chemical formula of the salt, (C12H18N4OS) (Cr2O7) (symbolically ThHCr2O7), 
has been established by UV/Vis spectra absorbance of about 360nm. 
Instrument 
               Shimadzu UV Visible spectrophotometer, Model 1800 
Reagent 
0.01% potassium dichromate solution  
Sample Preparation 
10g of powdered plant material was homogenized with ethanolic sodium hydroxide 
(100mlL. The plant extract was filtered and used as a sample. 
Procedure  
Thiamine was weighed and dissolved in water to get stock solution of 2mg/mL. 
Further dilutions were made to get the concentrations ranging from 100-500µg/mL. To 10mL 
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of sample, 10mL of potassium dichromate solution was added and the colour produced was 
measured at 360nm. A calibration curve was constructed by plotting concentration versus 
absorbance of thiamine (Fig.12). The above procedure was repeated for the plant extract and 
the absorbance was measured at 360nm and the readings were tabulated in Table 9. The 
amount of vitamin B1 present can be determined by linear regression analysis. The vitamin B1 
content was expressed as mg/g of extract. 
Estimation of vitamin B2 
Principle 
              The estimation of vitamin B2 was carried out using the method of  Okwu, D.E and 
C.Joshi with slight modification. Riboflavin was treated with potassium permanganate 
(KMnO4) and hydrogen peroxide (H2O2). Mixing of hydrogen peroxide solution, whereupon 
the permanganate colour is destroyed, excess oxygen is expelled and then sodium sulphate 
was added and an yellow colour was obtained. The absorbance of the colour was measured at 
550nm by UV/Vis spectrophotometer. 
Instrument 
             Shimadzu UV Visible spectrophotometer, Model 1800 
Reagent 
0.5% potassium permanganate. 
30% hydrogen peroxide 
40% sodium sulphate 
Sample Preparation 
10g of powdered plant material was extracted with 50% ethanol solution and shaken 
for 1h. The plant extract was filtered and used as a sample. 
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Procedure  
Riboflavin was weighed and dissolved in water to get stock solution of 20mg/mL. 
Further dilutions were made to get the concentrations ranging from 2-10mg/mL. To 15mL of 
sample and 10mL of 0.5% potassium permanganate and 1mL of 30% hydrogen peroxide 
were added and allowed to stand over a hot water bath for about 30min. 2mL of 40% sodium 
sulphate was added. This was made up to 5mL. The absorbance of the chromogen was 
measured at 550nm in a UV visible spectrophotometer. A calibration curve was constructed 
by plotting concentration versus absorbance of riboflavin (Fig. 13). The above procedure was 
repeated for the plant extract and the absorbance was measured at 550nm and the readings 
were tabulated in Table 10. The amount of vitamin B2 present can be determined by linear 
regression analysis. The vitamin B1 content was expressed as mg/g of extract. 
Estimation of vitamin C [113-114] 
Principle 
 The estimation of vitamin C was carried out using the method of Sarojini et al., with 
slight modifications. The keto group of ascorbic acid undergoes a condensation reaction with 
2,4 dinitro phenyl hydrazine to form a hydrazone which is orange yellow and has an 
absorbance of about 520nm. 
Instrument 
            Shimadzu UV Visible spectrophotometer, Model 1800 
Reagents  
0.2% dinitro phenyl hydrazine  
85% sulphuric acid 
Sample Preparation 
  Methanolic extract of Citrullus lanatus plant extract was and used as a sample. 
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Procedure  
Ascorbic acid was weighed and dissolved in water to get stock solution of 1mg/mL. 
Further dilutions were made to get the concentrations ranging from 40-200µg/mL. To 1mL of 
sample 0.5mL of di nitro phenyl hydrazine solution was added and incubated for 3h at 37ºC. 
After 3h, 2.5mL of 85% sulphuric acid was added and the absorbance was measured after 
30min at 520nm. A calibration curve was constructed by plotting concentration versus 
absorbance of ascorbic acid (Fig.14). The procedure was repeated for the plant extract as 
above and the absorbance was measured at 520nm after 3h and the readings were tabulated in 
Table 11. The amount of vitamin C present can be determined by linear regression analysis. 
The vitamin C content was expressed as mg/g of extract. 
SECTION C - CHROMATOGRAPHY 
Chromatography is a non-destructive procedure for resolving a complex mixture into 
its individual fractions or compounds. "Chromato" "graphy" derives its name from two words 
as chromo= colour and graphy= writing. i.e colour bands are formed in the procedure which 
are measured or analysed. It is defined as the process of separation of the individual 
components of a mixture based on their relative affinities towards stationary and mobile 
phases. These two phases can be can be solid-liquid, liquid-liquid or gas-liquid.  
Principle  
The samples are subjected to flow by mobile liquid onto or through the stable 
stationary phase. The sample components are separated into fractions based on their relative 
affinity towards the two phases during their travel. The fraction with greater affinity to 
stationary layer travels slower and shorter distance while that with less affinity travels faster 
and longer. Overall available chromatography techniques for regular analysis include, 
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a) Column chromatography. 
b) High performance liquid chromatography. 
c) Gas chromatography. 
d) Ion-exchange chromatography. 
e) Size exclusion chromatography. 
f) Thin layer chromatography. 
g) High performance thin layer liquid chromatography. 
h) Paper chromatography. 
i) Affinity chromatography.  
THIN  LAYER CHROMATOGRAPHY[115] 
The term “thin-layer chromatography”, introduced by E. Stahl in 1956, means a 
chromatographic separation process in which the stationary phase consists of a thin layer 
applied to a solid substrate or “support”. Thin layer chromatography (TLC) and high 
performance thin layer chromatography (HPTLC) – now also called planar chromatography. 
Thin-layer chromatography or TLC, is a solid-liquid form of chromatography where 
the stationary phase is normally a polar absorbent and the mobile phase can be a single 
solvent or combination of solvents. TLC is a quick, inexpensive microscale technique that 
can be used to: 
 • determine the number of components in a mixture 
 • verify a substance’s identity 
 • monitor the progress of a reaction 
 • determine appropriate conditions for column chromatography. 
 • analyze the fractions obtained from column chromatography.  
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Principle 
 TLC is based on the principle of adsorption. The separation depends on the relative 
affinity of compounds towards stationary and mobile phase. The compounds under the 
influence of mobile phase (driven by capillary action) travel over the surface of stationary 
phase and during this movement, the compounds with higher affinity to stationary phase 
travel slowly while the others travel faster. Thus separation of components in the mixture is 
achieved. [122-126] 
Preparation of TLC Plates 
 The adsorbent (silica gel G) slurry was prepared in water in the ratio of (1: 2). The 
glass plates (20cm x 5cm) were cleaned and laid in a row as a template, the suspension was 
poured into Stahl TLC spreader, which was adjusted to 0.25mm thickness and coated in a 
single passage of the spreader over them. These plates were air dried and activated in hot air 
oven at 105ºC for 30min and kept in a dessicator. The plates were used as the stationary 
phase or Pre-coated aluminum plates coated with silica gel G F254 (Merck) were also used for 
analysis.  
Sample application  
The extracts were dissolved in mobile phase and the spot was applied on the TLC 
plates using capillary tube. 
Development of the chromatogram 
After drying of the spot, the plates were developed in a chromatographic tank 
containing the solvent system. After one third of the plate was developed the plates were 
taken outside and dried. The TLC plate was examined visually or under UV light 
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Solvent system I 
 Stationary phase  - Silica gel G 
Mobile phase        - Toluene : Ethyl Acetate : Methanol (7:2:1) 
Detecting agent    - visual & UV light 
Solvent system II 
Stationary phase  - Silica gel G 
Mobile phase       - Chloroform : Methanol (9.5:1) 
            Detecting agent   - visual & UV light 
The Rf values were calculated using the formula [Distance travelled by solute/ Distance 
travelled by solvent]. The phytochemical evaluation of methanolic extract of Citrullus 
lanatus was carried out by using TLC studies. The results are presented in Table 12 and Fig 
15 & 16. 
HIGH PERFORMANCE THIN LAYER CHROMATOGRAPHY 
High performance thin layer chromatography (HPTLC) is an enhanced form 
of thin layer chromatography (TLC). A number of enhancements can be made to the basic 
method of thin layer chromatography to automate the different steps, to increase the 
resolution achieved and to allow more accurate quantitative measurements. [116] 
Analysis of pharmaceutical and natural compounds and newer drugs is commonly 
used in all the stages of drug discovery and development process. High-performance thin 
layer chromatography is one of the sophisticated instrumental techniques based on the full 
capabilities of thin layer chromatography. The advantages of automation, scanning, full 
optimization, selective detection principle, minimum sample preparation, hyphenation, and so 
on enable it to be a powerful analytical tool for chromatographic information of complex 
mixtures of pharmaceuticals, natural products, clinical samples, food stuffs, and so on. [117] 
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Principle 
HPTLC take place in high speed capillary flow range of the mobile phase. There are 
three main steps in HPTLC 
1] sample to analyzed to chromatogram layer volume precision and suitable position are 
achieved by use of suitable instrument. 
2]solvent (mobile phase) migrates the planned distance in layer(stationary) by capillary 
action in this process sample separated in its components. 
3] separation tracks are scanned in densitometer with light beam in visible or uv region.[118] 
The phytochemical evaluation of methanolic extract of Citrullus lanatus was carried 
out by using HPTLC studies. The results are presented in Table 13and Fig. 17 to 20. 
HPTLC fingerprint Development 
Instrument used 
CAMAG TLC Scanner 3 "Scanner3-070408"S/N 070408(1.41.21) was used for 
detection and CAMAG Linomat 5 sample applicator was used for the application of the track. 
Twin trough plate development chamber was used for development of chromatogram. 
Software used was winCATS 1.4.3 
Sample 
The Methanolic extract of Citrullus lanatus was dissolved in mobile phase and 2l 
sample is applied as 8mm band was used for taking HPTLC fingerprint.  
Stationary Phase 
HPTLC plates silica gel 60 F 254 
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Mobile phase 
Toluene: ethyl acetate: methanol (7: 2: 1) was used as the mobile phase for 
development of chromatogram. The mobile phase was taken in a CAMAG twin trough glass 
chamber. 
Detection wavelength 
The developed plates were examined at wavelength 254 and 366nm and @520nm in 
Densitometry TLC Scanner 3. The TLC visualization, 3D display of the finger print profile 
and peak display at 254 and 366nm are presented in Table 13 and Fig 17 to 20. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter VI                                                             Phytochemical Evaluation 
 
Department of Pharmacognosy, MMC.   65 
 
RESULTS AND DISCUSSION 
SECTION A - PRELIMINARY PHYTOCHEMICAL SCREENING 
               The results obtained for the preliminary phytochemical screening of the aqueous 
and methanolic extract of citrullus lanatus leaf was presented in Table 5. 
          Table. 5: Preliminary phytochemical screening for the aqueous and methanolic  
                                              extract of  Citrullus lanatus leaf                                                          
S. 
No. 
TEST 
RESULTS 
Aqueous extract Methanolic extract 
1. TEST FOR CARBOHYDRATES   
 a. Molisch’s test + + 
 c. Benedict’s test + + 
 b. Fehling’s test + + 
2. TEST FOR ALKALOIDS   
 a. Mayer’s reagent + + 
 b. Dragendroff’s reagent + + 
 c. Hager’s reagent + + 
 d. Wagner’s reagent + + 
3. TEST FOR PHYTOSTEROLS   
 a. Salkowski’s test + + 
 b. Libermann- burchard’s test + + 
4. TEST FOR GLYCOSIDES   
 a. Anthraquinone glycosides - - 
     i) Borntrager’s test - - 
     ii) Modified Borntrager’s test - - 
 b. Cardiac glycosides   
     i) Keller Killiani test  + + 
5. TEST FOR PROTEINS   
 a. Millon’s test + + 
 b. Biuret test + + 
 AMINO ACIDS   
 a. Ninhydrin test + + 
6. TEST FOR MUCILAGE - - 
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7. TEST FOR FLAVONOIDS   
 a. Shinoda test + + 
 b. Alkali test + + 
 c. Acid test + + 
8. TEST FOR TERPENOIDS + + 
9. TEST FOR PHENOLIC COMPOUNDS   
 a. 5% Ferric chloride solution + + 
 b. Lead acetate solution + + 
 c. Bromine water + + 
 d. Acetic acid solution                                     + + 
 e. Dilute iodine solution + + 
 f. Tannic acid + + 
10. TEST FOR TANNINS   
 FeCl3 test  + + 
11. TEST FOR SAPONINS   
 Foam test + + 
12. TEST FOR VOLATILE OILS - - 
                 (+) indicates positive reaction          (-) indicate negative reaction 
 The preliminary phytochemical screening procedure of the aqueous and methanolic 
extract of Citrullus lanatus leaf showed the presence of carbohydrates, alkaloids, 
phytosterols, cardiac glycoside, protein and amino acids, flavanoids, terpenoids, phenolic 
compounds, tannins, saponins and volatile oil were absent. 
SECTION B - QUANTITATIVE ESTIMATION OF PHYTOCONSTITUENTS 
Estimation of total phenols 
 The results for the total phenol estimation of methanolic extract of Citrullus lanatus 
are tabulated in Table 6 and Fig.9. 
 
 
Chapter VI                                                             Phytochemical Evaluation 
 
Department of Pharmacognosy, MMC.   67 
 
Table 6: Total phenolic content in ethanolic extract of Citrullus lanatus 
in terms of gallic acid equivalents 
 
S. 
No. 
Conc. of 
gallic acid 
in µg/mL 
Absorbance at 
760nm 
Conc. of  
extract in 
µg/mL 
Abs at 
760nm* 
Amount of total 
phenolic content 
in terms 
mgGAE/g of 
extract* 
1 2 0.229 ± 0.010 50 0.256±0.004 43.90±0.304 
2 4 0.452 ± 0.006 100 0.578±0.004 50.20±0.373 
3 6 0.695 ± 0.005    
4 8 0.918 ± 0.031    
5 10 1.162 ± 0.028  Average 47.05±0.338 
* mean of three readings ±SEM 
                 Fig . 9: Calibration curve of Gallic acid 
                                 
The linear regression equation was found to be y=0.116x-0.004 while the correlation 
coefficient was found to be 0.9998. The amount of phenol content present in the extract in 
terms mg GAE/g of extract was found to be 47.05 ± 0.338 by using the above linear 
regression equation. 
Estimation of total flavonoids 
 The results for the total flavonoid estimation of methanolic extract of Citrullus lanatus 
are tabulated in Table 7 . 
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Table 7: Total flavonoid content per gram of extract in terms of quercetin 
by aluminium chloride method 
 
S. 
No. 
Conc. of 
quercetin 
in µg/mL 
Absorbance 
at 415nm 
Conc. of 
methanolic 
extract in 
µg/mL 
Absorbance 
at 415nm 
Amount of  total 
flavonoid content 
in terms mg 
quercetin 
equivalent/ g of 
extract 
1 20 0.589 ± 0.01 50 0.090±0.001 86.55±0.21 
2 40 1.151 ± 0.04 100 0.243±0.003 93.44±0.39 
3 60 1.710 ± 0.09    
4 80 2.390 ± 0.03    
5 100 3.112 ± 0.03  Average 89.99±0.30 
                                   *mean of three readings ± SEM 
Fig. 10 : Calibration curve of quercetin 
                             
The linear regression equation was found to be y=0.0307x-0.0432 while the 
correlation was found to be 0.9974. The amount of flavonoid content present in the extract in 
terms mg quercetin equivalent/g of extract was found to be 89.99 ± 0.30 by using the above 
linear regression equation. 
Total tannin estimation [12] 
The results for the total tannin estimation of methanolic extract of Citrullus lanatus are 
tabulated in Table 8. 
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Table 8: Total tannin content in ethanolic extract of Citrullus lanatus 
in terms of tannic acid equivalents 
 
S. No. 
Conc. of 
tannic 
acid in 
µg/mL 
Absorbance 
at 760nm 
Conc. of 
methanolic 
extract in 
µg/mL 
Absorbanc
e at 
760nm* 
Amount of 
total tannin 
content in 
terms mg 
tannic acid/g of 
extract* 
1 4 0.098 ± 0.020 10 0.060±0.03 260.60±1.51 
2 8 0.183 ± 0.010 20 0.131±0.07 292.42±2.00 
3 12 0.203 ± 0.010    
4 16 0.361 ± 0.200    
5 20 0.451 ± 0.100  Average 276.51±1.75 
     * mean of three readings ±SEM 
                                          Fig. 11 : Calibration curve of tannic acid 
                               
 Total tannin determination is carried out by spectrophotometry after oxidation of the 
analyte with the Folin–Denis reagent in alkaline medium. This method is based on a redox 
reaction and other reducing agents in the samples. 
The linear regression equation was found to be y = 0.022x + 0.003 while the 
correlation was found to be 0.9997. The amount of tannin content present in the methanolic 
extract of Citrullus lanatus in terms of  mg tannic acid/g of extract was found to be 290.9 ± 
0.12 by using the above linear regression equation. 
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Vitamic B1 Content 
The results for vitamin B1 content of methanolic extract of Citrullus lanatus are 
presented in Table 9.  
Table 9: Estimation of Vitamin B1 in Citrullus lanatus 
 *mean of three readings ± SEM 
Fig. 12: Calibration curve of thiamine 
 
The linear regression equation was found to be y = 0.0023x - 0.0501 and a correlation 
coefficient of 0.990. The amount of vitamin B1 content present in the methanolic extract of 
Citrullus lanatus was found to be 56.28 ± 0.004 mg/gm by using the above linear regression 
equation.       
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S. 
No. 
Conc. of 
Thiamine 
in µg/mL 
Absorbance 
at 360nm 
Conc. of 
methanolic 
extract in 
µg/mL 
Absorbance at 
360nm 
Amt of vitamin  
B1 present mg/ g 
of extract 
1 100 0.168 ± 0.001 100 0.286 ± 0.004 54.82 ± 0.006 
2 200 0.367 ± 0.002 200 0.321 ± 0.007 55.02 ± 0.006 
3 300 0.656 ± 0.002 300 0.456 ± 0.003 59.00 ± 0.002 
4 400 0.856 ± 0.001  
Average 56.28 ± 0.004 
5 500 1.172 ± 0.003  
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Vitamic B2 Content 
The results for vitamin B2 content of methanolic extract of Citrullus lanatus are 
presented in Table 10.  
                              Table 10: Estimation of Vitamin B2  in Citrullus lanatus 
 *mean of three readings ± SEM 
Fig. 13: Calibration curve of riboflavin 
                           
 The linear regression equation was found to be y = 0.0969x - 0.015 and a correlation 
coefficient of 0.9989. The amount of vitamin B2 content present in the methanolic extract of 
Citrullus lanatus was found to be 34.00 ± 0.009 mg/gm by using the above linear regression 
equation. 
y = 0.096x ‐ 0.015
R² = 0.998
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S. 
No. 
Conc. of 
Riboflavin 
in mg/mL 
Absorbance 
at 360nm 
Conc. of 
methanolic 
ext. in 
mg/mL 
Absorbance 
at 360nm 
Amt of vitamin   
B2 present mg/ g 
of extract 
1 2 0.161 ± 0.006 2 0.047 ± 0.004 31.99 ± 0.011 
2 4 0.377 ± 0.012 4 0.111 ± 0.007 32.50 ± 0.006 
3 6 0.555 ± 0.002 6 0.203 ± 0.003 37.29 ± 0.010 
4 8 0.766 ± 0.005    
5 10 0.958 ± 0.004    
    Average 34.00 ± 0.009 
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Vitamic C Content 
The results for vitamin C content of methanolic extract of Citrullus lanatus are 
presented in Table 11.  
Table 11 : Estimation of Vitamin C in Citrullus lanatus 
 *mean of three readings ± SEM 
Fig.14 : Calibration curve of ascorbic acid 
 
       
 
 
 
             
 The linear regression equation was found to be y = 0.0027x + 0.012 and a 
correlation coefficient of 0.9982. The amount of vitamin C content present in the methanolic 
extract of Citrullus lanatus was found to be 245.37 ± 0.06mg/gm by using the above linear 
regression equation.       
S. 
No. 
Conc. of 
ascorbic 
acid in 
µg/mL 
Absorbance 
at 520nm 
Conc. of 
methanolic 
ext in 
µg/mL 
Absorbance 
at 520nm 
Amt of vitamin 
C present / g of 
extract 
1 40 0.135 ± 0.000 100 0.076 ± 0.004 237.03 ± 0.006 
2 80 0.265 ± 0.015 200 0.137 ± 0.007 253.70 ± 0.006 
3 120 0.346 ± 0.010    
4 160 0.468 ± 0.011    
5 200 0.525 ± 0.010    
    Average 245.37 ± 0.006 
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SECTION C – CHROMATOGRAPHY 
THIN LAYER CHROMATOGRAPHY 
               The number of spots, Rf value of the same and the colour of the spots under UV 
light 366nm and visible light is presented in Table 12 and the photograph of the plate is 
presented in Figs. 15 & 16.   
Table 12:  Phytochemical evaluation of methanolic extract of Citrullus lanatus by TLC 
studies 
 
S. No Solvent system Detecting agent 
No. of 
spots Colour of spots 
Rf 
values 
1. 
Toluene: Ethyl 
acetate : 
Methanol  
(7 : 2 :1) 
 
Under UV at 
366nm 
 
 
5 
Orange 0.94 
Dark orange 0.84 
Dark red 0.72 
Light pink 0.45 
Light pink 0.37 
Under Visible 
light 
 
 
6 
Yellow 0.92 
Brown 0.82 
Dark green 0.72 
Yellowish green 0.58 
Yellowish green 0.47 
Yellow 0.35 
2 
Chloroform: 
Methanol 
    (9.5 : 1) 
 
Under UV at 
366nm 
 
 
4 
Dark brown 0.90 
Dark orange 0.72 
Yellow 0.68 
Light pink 0.46 
Under Visible 
light 
 
 
 
6 
Dark green 0.92 
Yellow 0.74 
Yellow 0.70 
Light green 0.52 
Brown 0.46 
Brown 0.34 
 
The extract showed 5 spots at 366nm and 6 spots at visible light. The Rf value of 0.72, 
0.37 and 0.45 may be due to the presence of flavonoids, phenolic compounds and tannin. 
When viewed under UV at 366m and visible light after development in the mobile phase 
namely chloroform: methanol (9.5:1). The Rf value of 0.9 and 0.72 may be due to the 
presence of Cucurbitacin glucoside B and Cucurbitacin glucoside E.  The extract also showed 
SECTION C - CHROMATOGRAPHY 
THIN LAYER CHROMATOGRAPHY 
Fig. 15 :  TLC analysis of methanolic extract  of Citrullus lanatus @ 366nm and            
Visible light  
 
 
                      Mobile phase  - Toluene : Ethyl acetate : Methanol (7: 2 : 1) 
 
 
 
 
       @ 366nm    @ Visible light                                              
                
  
 
 
 
 
 
  
       Fig. 16 :  TLC analysis of methanolic extract  of Citrullus lanatus  @ 366nm and 
       Visible light 
        
        
                                     Mobile Phase : Chloroform : Methanol (9.5 : 1) 
 
 
 
 
      @ 366nm        @ Visible light 
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different Rf value under UV at 366nm and Visible light. The Rf may be due to the presence of 
different active principle might be responsible for the therapeutic activity. 
HIGH PERFORMANCE THIN LAYER CHROMATOGRAPHY 
The visualization of the HPTLC plate of methanolic extract of Citrullus lanatus at 
254nm and 366nm is presented in Fig 17. The photo of plate at 254nm showed the presence 
of 8 spots while at 366nm showed the presence 8 spots.                               
The 3D display of the fingerprint profile and the peak display of methanolic extract of 
Citrullus lanatus at 254nm and 366nm is presented in Figs 18. The display at 254nm shows 
the presence of 8 peaks while at 366nm shows the presence 8 peaks. The Rf values of the 
peaks along with the area under the curve for each peak at 254 and 366 nm are tabulated in 
Table 13. 
Table 13: Rf value of the spots and their area under curve at 254 and 366nm 
S. 
No 
Rf Value    @ 254nm AREA (AU)  @ 254nm 
TRACK TRACK 
1 2 3 4 1 2 3 4 
1 0.38 0.46 0.71 0.15 9798.0 27344.1 1187.6 248.6 
2    0.18    156.4 
3    0.36    1320.9 
4    0.45    17028.3 
5    0.65    1513.1 
6    0.72    326.7 
7    0.77    291.7 
8    0.84    2203.4 
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S. No 
@366nm 
Rf Value AREA (AU) 
1 2 
1 0.15 758.8 
2 0.18 135.7 
3 0.39 1647.0 
4 0.50 1881.2 
5 0.65 9744.8 
6 0.72 941.5 
7 0.80 348.2 
8 0.85 2984.6 
 
The HPTLC finger print profile of the methanolic extract of Citrullus lanatus  Rf 
values compared with standard quercetin, gallic acid and catechin. The methanolic extract of 
Citrullus lanatus Rf values also coincided with standard Rf  values and hence it may be 
confirmed that the methanolic extract showed the presence of quercetin, gallic acid and 
catechin. 
 
 
                                          Fig.17:  Visualization of TLC plate 
                      @ 254nm    @366nm                               
          
 
 
Fig.18: 3D Display of the extract and standards at 254 & 366nm                        
@ 254nm                         @366nm 
                                       
 
 
 
 
 
     
                                         Fig.19:  Overlain Spectral Display 
                             For catechin       For gallic acid 
                        
                                                                    For quercetin 
                                      
Fig.20:  Peak Display 
Track 1: Catechin,     Track 2: Gallic acid,  
Track 3: Quercetin,   Track 4: Methanolic extract of Citrullus lantus leaf. 
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CHAPTER VII 
     PHARMACOLOGICAL EVALUATION[119-120] 
The word pharmacology is derived from Greek words pharmacon (an active principle) 
and logos (a discourse or treatise). It is the science that deals with drugs. It consists of 
detailed study of drug, particularly their actions on living animal’s organ and tissue. The 
object of pharmacology is mainly to provide such scientific data, using which one can choose 
a drug treatment of proven efficacy and safety from various options available, so suit the 
patient. 
For thousand of years most drugs were crude natural products of unknown 
composition and limited efficacy. The overall effect of these substances on the body was 
rather imprecisely known, but how the same were produced was entirely unknown. The drugs 
have been purified, chemically characterised and a vast variety of highly potent and selective 
new drugs have been developed.  
SECTION A – IN VITRO ANTIOXIDANT ACTIVITY 
An antioxidant is a chemical that prevents the oxidation of other chemicals. They 
protect the key cell components by neutralizing the damaging effects of free radicals, which 
are natural by- products of cell metabolism.[121-122]. 
Free radicals may be either oxygen derived (ROS, reactive oxygen species) or 
nitrogen derived (RNS, reactive nitrogen species). The oxygen derived molecules are O2-  
Superoxide], HO [hydroxyl] ,HO2 [hydroperoxyl], ROO [peroxyl], RO [alkoxyl] as free 
radical and H2O2 oxygen as non-radical. Nitrogen derived oxidant species are mainly NO 
[nitric oxide], ONOO [peroxy nitrate], NO2 [nitrogen dioxide] and N2O3 [dinitrogen trioxide]. 
[123-124] 
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             In a normal cell, there is appropriate oxidant: antioxidant balance. However, this 
balance can be shifted, when production species is increased or when levels of antioxidants 
are diminished. This stage is called oxidative stress. Oxidative stress results in the damage of 
biopolymers including nucleic acids, proteins, polyunsaturated fatty acids and carbohydrates. 
            Oxidative stress causes serious cell damage leading to a variety of human diseases 
like Alzheimer’s disease, Parkinson’s disease, atheroscleorosis, cancer, arthritis, 
immunological incompetence and neurodegenerative disorders, etc. [125-127]. 
Antioxidants and Health 
 Antioxidants are man-made or natural substances that may prevent or delay 
some types of cell damage. Diets high in vegetables and fruits, which are good 
sources of antioxidants, have been found to be healthy; however, research has 
not shown antioxidant supplements to be beneficial in preventing diseases. 
Examples of antioxidants include vitamins C and E, selenium, and 
carotenoids, such as beta-carotene, lycopene, lutein, and zeaxanthin. 
 Rigorous scientific studies involving more than 100,000 people combined 
have tested whether antioxidant supplements can help prevent chronic 
diseases, such as cardiovascular diseases, cancer, and cataracts. In most 
instances, antioxidants did not reduce the risks of developing 
these diseases.[128] 
Medicinal herb as Antioxidants: 
           Indian medicinal herbs were extensively investigated as vital sources of antioxidants. 
Allium cepa (Onion), Allium sativum (Garlic), Aloe vera (Indian aloe), Amomum subulatum 
(greater cardamom, Bari elachi), Andrographis paniculata (The creat), Asparagus racemosus 
(Shatavari), Azadirachta indica (Neem, Nimba), Bacopa monniera (Brahmi), Camellia 
sinensis (Green tea), Cinnamomum verum (Cinnamon), Curcuma longa (Turmeric), Emblica 
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officinalis (Indian gooseberry), Glycyrrhiza glabra (Yashtimadhu), Withania somnifera 
(Ashwagandha), and  Zingiber officinalis (Ginger). [129] 
MATERIALS AND METHODS 
Method 1: Free radical Scavenging activity using diphenyl picryl hydrazyl (DPPH) free 
radical  
 
The free radical scavenging activity of the extracts is evaluated by assessing their 
ability to reduce the colour of DPPH in ethanol according to Brand Williams [130]. DPPH 
stable free radical method is an easy, rapid and sensitive way to survey the antioxidant 
activity of specific compound or plant extracts.  
Principle 
A simple method that has been developed to determine the antioxidant activity of 
plants utilizes the stable 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical. The odd electron in 
the DPPH free radical gives a strong absorption maximum at 517nm and is purple in colour.  
The colour turns from purple to yellow as the molar absorptivity of the DPPH radical at 
520nm reduces when the odd electron of DPPH radical becomes paired with hydrogen from a 
free radical scavenging antioxidant to form the reduced DPPH-H.  The resulting 
decolorization is stoichiometric with respect to number of electrons captured [130-131].  
                                              DPPH. + AH   DPPH – H + A. 
Instrument 
Shimadzu UV Visible spectrometer, Model 1800 
Reagents 
0.1mM Diphenyl Picryl Hydrazyl Radical in ethanol 
Procedure [132-133] 
A stock solution of 0.5mg/mL concentration of methanolic extract of C. lanatus was 
prepared. To 1mL of various concentrations of test samples, 4mL of DPPH was added. 
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Control was prepared without sample in an identical manner. DPPH was replaced by ethanol 
in case of blank. The reaction was allowed to be completed in the dark for about 30min. Then 
the absorbance was measured at 517nm. Vitamin C was used as standard. The percentage 
scavenging was calculated using the formula [(Control-Test)/Control] x 100. A graph was 
constructed by plotting concentration versus percentage inhibition and a linear regression 
equation calculated. The concentration of the sample required for 50% reduction in 
absorbance (IC50) was calculated using linear regression analysis.  A triplicate reading was 
taken and average was calculated.  The results obtained are presented in Table 14 and Fig.21.  
Method 2: Total antioxidant activity by Phosphomolybdenum Method. [134-135] 
Principle 
            Total antioxidant capacity was measured by spectrophotometric method of Prieto et 
al. Phosphomolybdenum method assay is based on the reduction of Mo (VI) to Mo (V) by the 
sample analyte and the subsequent formation of green phosphate Mo (V) complex at acidic 
pH and the absorbance was measured at 695nm. This method is used to determine the total 
antioxidant activity of samples. 
                  Mo6+         →        Mo5+ 
Reagents 
0.6M sulphuric acid 
28mM sodium phosphate 
4mM   ammonium molybdate 
Instruments 
         Shimadzu UV Visible spectrophotometer, Model 1800 
 Procedure 
  An aliquot of 0.3mL of different concentrations of sample solution was combined 
with 2.7mL of the reagent solution (H2SO4, sodium phosphate and ammonium molybdate). In 
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case of blank, 0.3mL of msethanol was used in place of sample. The tubes were incubated for 
95°C for 90min. After the mixture was cooled to room temperature, the absorbance was 
measured at 695nm against blank. Ascorbic acid was used as a standard and was treated in a 
similar manner. The total antioxidant activity is expressed as the number of equivalents of 
ascorbic acid (µg/g). The results were tabulated in table 15 and the graphical representation 
is presented in Fig. 22. 
Method 3:  Reducing power assay [134] 
Principle: 
            This is a spectrophotometric method and is based on the principle that an increase in 
absorbance of the reaction mixture as concentration increase indicates an increased 
antioxidant activity. 
            The assay is based on the reduction of ferric in potassium ferricyanide to ferrous to 
form potassium ferrocyanide by the sample and the formation of Prussian blue colour 
complex when treated with ferric chloride. The absorbance of the blue complex is measured 
at 700nm. 
Instrument 
Shimadzu UV Visible spectrophotometer. Model 1800 
Reagents 
           1% potassium ferricyanide 
           10% trichloro acetic acid. 
           0.2M, phosphate buffer (pH 6.6) 
          0.1% ferric chloride. 
Procedure 
           Various concentration of methanolic extracts of Citrullus lanatus was mixed with 
0.75mL phosphate buffer and 0.75mL potassium ferricyanide [K3 Fe(CN6)], then the mixture 
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was incubated at 50°C for 20 min. 0.75mL of trichloro acetic acid was added to the mixture, 
which was then centrifuged at 3000rpm for 10min. Finally 1.5mL of the supernatant solution 
was mixed with 1.5mL of distilled water and 0.1mL of ferric chloride (FeCl3) and absorbance 
was measured at 700nm in a UV-Visible Spectrophotometer. Ascorbic acid was used as 
standard and phosphate buffer used as blank. The absorbance of the final reaction mixture of 
three parallel experiments was expressed as mean ± standard error of mean. Increased 
absorbance of the reaction mixture indicates stronger reducing power. The results obtained 
are tabulated in table 16 and the graphical representation is presented in Fig. 23.    
Method 4: Ferric Reducing Antioxidant Power (FRAP) Assay [135] 
Total antioxidant activity is measured by FRAP assay of Benzie et al., 1999. The 
ferric reducing antioxidant power assay measures the potential of antioxidants to reduce the 
Fe3+ and 2,4,6 tripyridyl-s-triazyne (TPTZ) complex present in stoichiometric excess to the 
blue coloured Fe2+ complex which increases the absorbance at 593nm. 
Principle  
At low pH, reduction of ferric tripyridyl triazine (Fe III TPTZ) complex to ferrous 
form (which has an intense blue colour) can be monitored by measuring the change in 
absorption at 593nm. The reaction is non-specific, in that any half reaction that has lower 
redox potential, under reaction conditions, than that of ferric ferrous half reaction, will drive 
the ferrous (Fe III to Fe II) ion formation. The change in absorbance is therefore, directly 
related to the combined or “total” reducing power of the electron donating antioxidants 
present in the reaction mixture.  
Instrument 
            Shimadzu UV Visible spectrophotometer, Model 1800 
Reagents  
FRAP Reagent  
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a) Acetate buffer 30mM pH 3.6: Weigh 3.1g sodium acetate trihydrate and add 16 
ml of glacial acetic acid and make the volume to 1 L with distilled water. 
b) TPTZ (2, 4, 6-tripyridyl-s- triazine) (M.W. 312.34) 10mM in 40mM HCl 
c) FeCl3. 6H2O (M.W. 270.30) 20mM 
             The working FRAP reagent was prepared freshly by mixing a, b & c in 
the ratio of    10:1:1 at the time of use.  
 Procedure  
            The methanolic extract of Citrullus lanatus was dissolved in methanol to get a stock 
solution containing 1mg/mL. Varying quantities of the stock solution were added to 3mL of 
working FRAP reagent and absorbance was measured at 0min after vortexing at 593nm. 
Thereafter samples were placed at 37ºC in water bath and absorption was again measured 
after 4min. Ascorbic acid was used as standard. The result obtained for the FRAP assay are 
presented in the table 17 and Fig.24. 
SECTION B - LARVICIDAL ACTIVITY OF METHANOLIC EXTRACT OF 
CITRULLUS LANATUS[136-147] 
 
Malaria and other vector-borne diseases contribute to the major disease burden in 
India. One of the methods to control these diseases is to control the vectors for the 
interruption of disease transmission. In the past, synthetic organic chemical insecticides based 
intervention measures for the control of insect pests and disease vectors have resulted in 
development of insecticide resistance in some medically important vectors of malaria, 
filariasis, Japanese encephalitis, dengue, hemorrhagic fever, chikungunya and yellow fever 
transmitted by mosquitoes which cause millions of death every year.  Hence destroying  
mosquitoes is one method for preventing the above infections [147-148]. During the last decade, 
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various studies on natural plant products against mosquito vectors indicate them as possible 
alternatives to synthetic chemical insecticides. 
               The present study has attempted to study mosquito larvicidal property of C. lanatus 
against three mosquito species - Anopheles stephensi, Culex quinquefasciatus and Aedes 
aegypti  (Diptera: Culicidae).  
Preparation of stock solution of methanolic extract 
          A stock solution of 100mg/mL of the methanolic extract of the plant Citrullus lanatus 
was prepared by dissolving the required quantity of the extract in distilled water. 
Procedure for extract 
           The method adopted by Arivoli S and Samuel Tennyson 2012 was followed. The 
larvicidal activity of plant extract was carried out on late 3rd and early 4th instar larvae of 
Anopheles stephensi, a primary vector of urban malaria, Culex quinquefaciatus, a common 
vector of filariasis, Aedes aegypti, common vector of dengue and yellow fever. The mosquito 
larvae were obtained from ICMR, Madurai. Twenty larvae were released in 500mL beaker 
containing 200mL distilled water with varying concentrations of plant extract. The larvae 
were provided with dog biscuit and yeast powder in a ratio of 3:2 as nutrients. The 
experiments were carried out a room temperature (26°C ± 2°C). Three replicates of each 
concentration were run under the same microclimate conditions along with untreated control. 
The mortality was monitored for 24h. The results obtained are presented in Table 18 to 20 
and Fig. 25 to 27.[148]. 
Data analysis[149-150] 
LC50 (lethal concentration to cause 50% mortality in the population) and LC90 
(lethal concentration to cause 90% mortality in the population) were determined by plotting 
the regression line as described by Finney. The percentage mortality was calculated using 
Abbot’s formula and the data so obtained was analyzed by probit analysis (Finney 1989) by 
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using the software Minitab-15 for dose and time mortality regression lines. The purpose of 
the probit transformation is to straighten the line so we can estimate LC 50 more easily. 
Percentage Mortality = %Mortality in treated- %Mortality in control  X 100 
                                                   100 - % Mortality in control 
 
SECTION C - PANCREATIC LIPASE INHIBITION ASSAY[151-153] 
Obesity is a medical complication caused by an imbalance between energy intake and 
expenditure and is broadly recognized as a major public health problem. Obesity can lead to 
variety serious diseases, including hypertension, hyperlipidemia, atherosclerosis, and type II 
diabetes and thus indirectly leading to aging. The inhibitors of digestive lipases reduce 
dietary fat absorption and hence act as anti-obesity agents. New Pancreatic lipase inhibitors 
derived from natural sources especially from medicinal herbs are used for the treatment of 
obesity.  
Pancreatic lipase    
Pancreatic lipase (PL) is an enzyme, secreted from the pancreas and plays an excellent 
role in the absorption of triglyceride in the small intestine. Dietary fats are composed of about 
95% triacylglycerols (TG). Pancreatic lipase hydrolyses the water insoluble triacylglycerols 
in the intestinal lumen and thereby used for the dietary fat absorption. 
Pancreatic lipase inhibitors 
Pancreatic lipase inhibitors are considered to be a valuable therapeutic agent for 
treating diet-induced obesity in humans as anti-obesity agents. Grape seed extracts, carnosic 
acid from the ethanolic extract of leaves of Salvia officinalis L (sage), flavan dimmers 
isolated from fruits of Cassia nomame (Leguminosae), the methanol extract of  Dioscorea 
nipponica,5-hydroxy-7-(41-hrdroxy-31-methoxyphenyl)-l-phenyl-3-heptone (HPH) and 3-
methylethergalangin from the rhizome of Alpinia officinarum  are examples of pancreatic 
lipase inhibitors of plant sources 
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Principle Lipases have certain roles in human pathogenesis and are a key enzyme catalyzes 
the hydrolysis of emulsified esters of glycerol and long chain fatty acids. Short chain fatty 
acids can be directly absorbed into the blood, while long-chain fatty acids and 
monoglycerides combine with   bile salts to form water soluble micelles. The micelles are 
absorbed into the mucosal cells of the intestine and the fatty acids and monoglycerides are 
resynthesized into triglycerides. Dietary triglyceride is usually stored in the adipose tissue. 
Pharmacological agents that reduce the absorption of dietary triglycerides, reduce the 
probability of the formation of atherosclerotic plaque. Triglyceride hydrolysis by pancreatic 
lipase is inhibited by physiological concentrations of bile salts. 
  An anti-obesity drug Orlistat, inhibits pancreatic lipase in the lumen of the 
gastrointestinal tract to decrease systemic absorption of dietary fat. 
Requirements 
 Chicken (Gallus domesticus) pancreas 
 Sucrose solution (0.01M) 
 Ammonium sulphate (50% saturation) 
 Phosphate buffer (pH7) 
 Olive oil 
 Pancreatic lipase 
 Orlistat (60mg) 
Procedure [153] 
Extraction of Lipase from Chicken (Gallus domesticus) pancreas 
 Pancreas of freshly slaughtered chicken was collected with the guidance of a 
veterinary surgeon. It was washed thoroughly and pancreatic lipase was placed in ice cold 
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sucrose solution (0.01M). The Pancreas was homogenized in 0.01M sucrose and centrifuged. 
The supernatant solution was separated and subjected to ammonium sulphate precipitation 
(50% saturation). The obtained white pellets after centrifugation was dissolved in sucrose 
solution and again saturated with 50% ammonium sulphate and centrifuged. Finally pellets 
were used as enzyme source by dissolving in phosphate buffer (pH 7).    
Determination of chicken pancreatic lipase activity 
The chicken pancreatic lipase activity was determined by incubating an emulsion 
containing 8mL of olive oil (Dietary fat), 0.4mL of  phosphate buffer and 1 mL of chicken 
pancreatic lipase for an hour. The reaction was stopped by addition of  1.5mL of a mixture 
containing acetone and 95% ethanol (1:1). The amount of  liberated fatty acid was 
determined by titrating the emulsion against 0.02M NaOH (standardized by potassium 
hydrogen phthalate) using phenolphthalein as an indicator. The end point is the appearance of 
pink colour. The volume of sodium hydroxide consumed was taken as (A). 
Pancreatic lipase inhibitory activity 
Pancreatic lipase inhibitory activity has been studied using Prashith Kekuda T R et al. 
method with slight modification. The plant extract of Citrullus lanatus was prepared in 
different concentrations such as 1.0mg/mL, 2.0mg/mL, 3.0mg/mL, 4.0mg/mL, 5.0mg/mL. A 
100µL of each concentration of sample was mixed with 8 mL of olive oil, 0.4 mL phosphate 
buffer and 1 mL of Chicken pancreatic lipase and it was incubated for 60mins. The reaction 
was stopped by the addition of 1.5 mL of a mixture containing acetone and 95% ethanol 
(1:1). Appearance of pink colour from yellow colour shows the liberated fatty acids, which 
was determined by titrating the solution against 0.02M NaOH (standardized by potassium 
hydrogen phthalate) using phenolphthalein as an indicator and the percentage inhibition of 
lipase activity was calculated using the following formula , Lipase inhibition = [A-B/ B]  × 
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100, where A - Lipase activity, B -  Activity of lipase when incubated with the standard and 
test compounds and the results are tabulated in Table 21  and the pictorial representations are 
presented in Fig.28. 
SECTION D - IN VITRO ANTI CANCER ACTIVITY (BREAST CANCER 
ACTIVITY BY USING HUMAN BREAST CANCER CELL LINES) [154-156] 
 
Cancer is a group of many different diseases that have some important things in 
common. They all arise in cells, the body’s unit of life. The body is made up of many types of 
cells. Normally, cells grow and divide to produce more cells only when the body needs them. 
Sometimes cells keep dividing when new cells are not needed. These cells may form a mass 
of extra tissue called a growth or tumor. Tumors can be benign or malignant. 
 Benign tumors are not cancer. They can usually be removed, and in most cases, they 
don’t come back. Most important, the cells in benign tumors do not invade other tissues and 
do not spread to other parts of the body. Benign tumors are not a threat to life. 
Malignant tumors are cancer. Cells in these tumors can invade and damage nearby 
tissues and organs. Also cancer cells can break away from a malignant tumor and enter the 
bloodstream or lymphatic system. That is how breast cancer spreads and forms secondary 
tumors in other parts of the body. The spread of cancer is called metastasis. 
Breast cancer 
The most common type of breast cancer begins in the lining of the ducts and is called 
ductal carcinoma. Another type, called lobular carcinoma, arises in the lobules.The risk of 
breast cancer increases gradually as a woman gets older. The risk factors for breast cancer 
include age, personal and family health history, genetic changes, prior radiation therapy, 
reproductive and menstrual history, race, breast density, overweight and obesity, physical 
inactivity, and alcohol consumption. The various symptoms include a lump or thickening in 
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or near the breast or underarm area,  change in the size or shape of the breast, fluid discharge 
from the nipple, especially if it's bloody  
Treatment 
Surgery is the most common treatment for breast cancer.  An operation to remove the 
breast (or as much of the breast as possible) is a mastectomy. An operation to remove the 
cancer but not the breast is called breast-sparing surgery or breast-conserving surgery. 
Lumpectomy and segmental mastectomy (also called partial mastectomy) are types of breast-
sparing surgery. They usually are followed by radiation therapy to destroy any cancer cells 
that may remain in the area. In most cases, the surgeon also removes lymph nodes under the 
arm to help determine whether cancer cells have entered the lymphatic system. 
Radiation therapy is the use of high-energy rays to kill cancer cells and stop them 
from growing. The therapy may be by external source or implant radiation. Some women 
receive both kinds of radiation therapy. 
Chemotherapy is the use of drugs to kill cancer cells. It is generally a combination of 
drugs. The drugs may be given by mouth or by injection. It is a systemic therapy because the 
drugs enter the bloodstream and travel throughout the body. 
Hormonal therapy is used to keep cancer cells from getting the hormones they need 
to grow. This treatment may include the use of drugs that change the way hormones work or 
surgery to remove the ovaries, which make female hormones. It is also a systemic 
treatmentand hence can affect cancer cells throughout the body. 
Advantages of Herbal Medicines compare with alternative therapy [157] 
Herbal medicine is one of the most commonly used complementary and alternative 
therapies (CAM) by people with cancer. Some studies have shown that as many as 6 out of 
every 10 people with cancer (60%) use herbal remedies alongside conventional cancer 
treatments.  
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Cell line 
The human breast cancer cell line (MCF-7) was obtained from National Centre for 
Cell Science (NCCS), Pune and grown in Eagles Minimum Essential Medium containing 
10% fetal bovine serum (FBS). The cells were maintained at 370C, 5% CO2, 95% air and 
100% relative humidity. Maintenance cultures were passaged weekly, and the culture 
medium was changed twice a week.  
Cell treatment procedure 
The monolayer cells were detached with trypsin-ethylene diamine tetraacetic acid 
(EDTA) to make single cell suspension and viable cells were counted using a hemocytometer 
and diluted with medium containing 5% FBS to give final density of 1x105 cells/ml. One 
hundred microlitres per well of cell suspension were seeded into 96-well plates at plating 
density of 10,000 cells/well and incubated to allow for cell attachment at 370C, 5% CO2, 95% 
air and 100% relative humidity. After 24h the cells were treated with serial concentrations of 
the test samples. They were initially dissolved in neat dimethyl sulfoxide (DMSO) and an 
aliquot of the sample solution was diluted to twice the desired final maximum test 
concentration with serum free medium. Additional four serial dilutions were made to provide 
a total of five sample concentrations. Aliquots of 100 µl of these different sample dilutions 
were added to the appropriate wells already containing 100 µl of medium, resulting in the 
required final sample concentrations. Following sample addition, the plates were incubated 
for an additional 48 h at 370C, 5% CO2, 95% air and 100% relative humidity. The medium 
containing without samples were served as control and triplicate was maintained for all 
concentrations.  
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MTT assay[158] 
3-[4,5-dimethylthiazol-2-yl]2,5-diphenyltetrazolium bromide (MTT) is a yellow water 
soluble tetrazolium salt. A mitochondrial enzyme in living cells, succinate-dehydrogenase, 
cleaves the tetrazolium ring, converting the MTT to an insoluble purple formazan. Therefore, 
the amount of formazan produced is directly proportional to the number of viable cells. 
After 48h of incubation, 15µL of MTT (5mg/mL) in phosphate buffered saline (PBS) 
was added to each well and incubated at 370C for 4h. The medium with MTT was then 
flicked off and the formed formazan crystals were solubilized in 100µl of DMSO and then 
measured the absorbance at 570nm using micro plate reader. The percentage cell viability 
was then calculated with respect to control as follows - % Cell viability = [A] Test / 
[A]control x 100. The results are tabulated in Table 22 & 23  and Photomicrograph of  
human breast cancer cell lines (MCF-7) presented in Fig. 29 & 30. 
SECTION E - IN VITRO ANTI DIABETIC ACTIVITY [159-163] 
Diabetes mellitus is a group of metabolic diseases in which a person has high blood 
sugar, either because the pancreas does not produce enough insulin, or because cells do not 
respond to the insulin that is produced. This high blood sugar produces the classical 
symptoms of polyuria (frequent urination), polydispsia (increased thirst) and polyphagia 
(increased hunger). Therefore a therapeutic approach to treat diabetes is to decrease 
postprandial hyperglycemia. This can be achieved by the inhibition of carbohydrate 
hydrolyzing enzymes like alpha amylase and alpha Glucosidase. 
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Three main types of Diabetes mellitus (DM) 
 Type 1 DM results from the body's failure to produce insulin, and currently requires 
the person to inject insulin or wear an insulin pump. This form was previously 
referred to as "insulin-dependent diabetes mellitus" (IDDM) or "juvenile diabetes". 
 Type 2 DM results from insulin resistance, a condition in which cells fail to use 
insulin properly, sometimes combined with an absolute insulin deficiency. This form 
was previously referred to as non insulin-dependent diabetes mellitus (NIDDM) or 
"adult-onset diabetes". 
 The third main form, gestational diabetes, occurs when pregnant women without a 
previous diagnosis of diabetes develop a high blood glucose level. It may precede 
development of type 2 DM. 
Other forms of diabetes mellitus include congenital diabetes, which is due 
to genetic defects of insulin secretion, cystic fibrosis-related diabetes, steroid diabetes 
induced by high doses of glucocorticoids, and several forms of monogenic diabetes.  
Symptoms  
             The symptons include high levels of sugar in the blood, unusual thirst, frequent 
urination, extreme hunger and loss of weight, blurred vision, nausea and vomiting, extreme 
weakness and tiredness, irritability, mood changes etc. 
Complications  
              The ccomplications of diabetes include eye, foot, skin complications, heart 
problems, hypertension, mental health, hearing loss, gum disease, gastroparesis, ketoacidosis, 
neuropathy, nephropathy, peripheral arterial disease, stroke, erectile dysfunction, 
infections and non healing of wounds 
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Medicinal plants used in treatment of diabetes  
These include Allium sativum, Eugenia jambolana, Momordica charantia Ocimum 
sanctum,  Phyllanthus amarus, Pterocarpus marsupium,  Tinospora cordifolia, Trigonella 
foenum graecum and Withania somnifera. 
Herbal formulations in the treatment of diabetes mellitus [164] 
  Diabetes mellitus in Ayurveda is known as Madhu-meha. Several Ayurvedic 
formulations have been used in the treatment of Diabetes mellitus for centuries. In addition to 
herbs, minerals find wide application in Ayurvedic prescription for diabetes. Medicinal herbs 
like Momordica charantia, Gymnema sylvestre, Enicostermma littorale, Pterocarpus 
marsupium, Salacia reticulate, Coccinia gluaca and Trigonella foneum graceum are 
prescribed as single powder drugs or in combination (poly-herbal).  
 Rasayana is an important branch of Ayurveda. The main goal of Rasayana therapy is 
better quality of life with increased lifespan. Rasayana includes drug formulation, dietary 
regimen and code of conduct. Many of the drugs used in Rasayana therapy in diabetes 
mellitus have excellent antioxidant properties, like Phyllanthus emblica, Azadirachta indica, 
Ocium sanctum and Tinospora cordifolia. The Rasayana approach to treat diabetes consists 
of Aeara Rasayana (antistress), Ajasrika Rasayana (dietary control), Osad Rasayana 
(Preventive), Naimittika Rasayana (hypoglycemic).  
Significance of herbal drugs compare with Allopathic Drugs 
Medicinal plants are being looked up once again for the treatment of diabetes. Many 
conventional drugs have been derived from prototypic molecules in medicinal plants.  
Metformin exemplifies an efficacious oral glucose-lowering agent. Its development was 
based on the use of Galega officinalis to treat diabetes. Galega officinalis is rich in guanidine, 
the hypoglycemic component. Because guanidine is too toxic for clinical use, the alkyl 
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biguanides synthalin A and synthalin B were introduced as oral anti-diabetic agents in Europe 
in the 1920s but were discontinued after insulin became more widely available. However, 
experience with guanidine and biguanides prompted the development of metformin.  
To date, over 400 traditional plant treatments for diabetes have been reported, 
although only a small number of these have received scientific and medical evaluation to 
assess their efficacy. The hypoglycemic effect of some herbal extracts has been confirmed in 
human and animal models. The World Health Organization Expert Committee on diabetes 
has recommended that traditional medicinal herbs be further investigated. 
Advantages of herbal medicine over Allopathic drugs 
 In India, it is proving to be a major health problem, especially in the urban areas. 
Though there are various approaches to reduce the ill effects of diabetes and its secondary 
complications, herbal formulations are preferred due to lesser side effects, low cost, widely 
available and less toxic compared with allopathic drugs. 
The present study of in-vitro anti-diabetic activity was carried out by following methods 
 Non-enzymatic glycosylation of haemoglobin Assay. 
 Glucose uptake in yeast cells 
 % inhibition of Glucose uptake in 5mM glucose concentrations. 
 % inhibition of Glucose uptake in 10mM glucose concentrations. 
 Alpha amylase inhibition assay. 
 Alpha glucosidase inhibition assay 
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METHOD I: NON-ENZYMATIC GLYCOSYLATION OF HAEMOGLOBIN ASSAY 
Glucose reacts non enzymatically with the NH2-terminal amino acid of the beta chain 
of human hemoglobin by way of a ketoamine linkage, resulting in the formation of 
hemoglobin AIc. Other minor components appear to be adducts of glucose 6-phosphate and 
fructose 1,6-diphosphate. These hemoglobins are formed slowly and continuously throughout 
the 120-day life-span of the red cell. There is a two- to threefold increase in hemoglobin AIc 
in the red cells of patients with diabetes mellitus. By providing an integrated measurement of 
blood glucose, hemoglobin AIc is useful in assessing the degree of diabetic control. 
Furthermore, this hemoglobin is a useful model of non-enzymatic glycosylation of other 
proteins that may be involved in the long-term complications of the disease.[165] 
The incubation of dialyzed hemoglobin with a number of phosphorylated glycolytic 
intermediates leads to the formation of covalent hemoglobin adducts that co-chromatograph 
with haemoglobin. From 7 to 12% of the hemoglobin can be modified after a 72-h incubation 
of an equimolar mixture of haemoglobin and the phosphorylated intermediate. The 
concentration of haemoglobin is elevated in patients with Diabetes mellitus. This presumably 
reflects the increased concentrations of glycolytic intermediates, which were found to be 
significantly elevated in the red cells of diabetic patients as compared with normal 
controls.[166]  
Principle 
Human bodies possess enzymatic and non- enzymatic antioxidative mechanisms 
which minimize the generation of reactive oxygen species, responsible for many degenerative 
diseases including diabetes. Increased concentration of glucose in the blood leads to its 
binding to hemoglobin which may result in the formation of the reactive oxygen species. An 
Chapter VII                                                          Pharmacological Evaluation 
Department of Pharmacognosy, MMC.   95 
 
increase in the glycosylation was observed on incubation of hemoglobin with the increasing 
concentration of the glucose over a period of 72h. [167-168] 
Reagents 
 2% glucose solution. 
 0.06% haemoglobin solution.    
  0.02% gentamycin solutions. 
 0.01 M phosphate buffer (pH 7.4) 
Procedure 
Anti diabetic activity of methanolic extract of the leaves of Citrullus lanatus were 
investigated by estimating degree of non-enzymatic haemoglobin glycosylation, measured 
spectrophotometrically at 520nm. Glucose (2%), haemoglobin (0.06%) and Gentamycin 
(0.02%) solutions were prepared in 0.01M phosphate buffer (pH 7.4). 1mL each of above 
solution was mixed with 1mL of various concentrations of the extract. The mixture was 
incubated in dark at room temperature for 72h. The degree of glycosylation of haemoglobin 
was measured spectrophotometrically at 520nm. α-tocopherol (Trolax) was used as a 
standard drug for assay. The percentage inhibition was calculated. All the tests were 
performed in triplicate. [169-170] 
The % inhibition was calculated using the following formula, 
% inhibition    =      Abs sample – Abs control   X 100 
                                                                     Abs sample 
 
Where Abs control is the absorbance of the control and Abs sample is the absorbance of the 
test sample. The results are tabulated in Table 24 and Fig. 33. 
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METHOD II: IN VITRO GLUCOSE UPTAKE IN YEAST CELLS 
 The rate of glucose transport across cell membrane in yeast cells system is presented. 
Regulation of glucose level in the blood of the diabetic patient can prevent the various 
complications associated with the disease. The maintenance of plasma glucose concentration 
for a long term under a variety of dietary conditions is one of the most important and closely 
regulated processes observed in the mammalian species. In Yeast glucose transport takes 
place through facilitated diffusion. After the treatment of the yeast cells with extract, the 
glucose uptake was found to increase in a dose dependent manner. The methanolic extract of 
Citrullus lanatus glucose uptake by yeast cells as compared to standard drug acarbose. [171-172] 
Principle 
In the glucose uptake in yeast cells method the glucose transport across the yeast cell 
membrane has been receiving attention as in vitro screening method for hypoglycaemic effect 
of various compounds/ medicinal plants. The transport of non metabolizable sugars and 
certain metabolizable glycosides suggest that sugar transport across the yeast cell membrane 
is mediated by stereospecific membrane carriers. It is reported that in yeast cells  glucose 
transport is extremely complex and it is generally agreed that glucose is transported in yeast 
is by a facilitated diffusion process. Facilitated carriers are specific carriers that transport 
solutes down the concentration gradient. This means that effective transport is only attained if 
there is removal of intracellular glucose. 
Reagents [171] 
 Baker’s yeast. 
 Glucose solution (5 and 10mM) 
 GOD solution 
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Procedure 
Yeast cells were prepared by commercial baker’s yeast was washed repeated 
centrifugation (3,000 rpm; 5min) in distilled water until the supernatant fluids were clear and 
a 10% (v/v) suspension was prepared in distilled water. 1mL of various concentrations of 
methanolic extract of Citrullus lanatus were added to 1mL of glucose solution (5 and 10mM) 
and incubated together for 10min at 37°C. Reaction was started by adding 100μL of yeast 
suspension, vortexed and further incubated at 37°C for 60min. After 60min, the tubes were 
centrifuged (2,500 rpm, 5min) and glucose was estimated in the supernatant by glucose 
oxidase method. The optical density 520 nm was measured. Acarbose was taken as standard 
drug. The percentage increase in glucose uptake by yeast cells was calculated using the 
following formula,   
 
                 Increase in glucose uptake (%)  =   Abs sample – Abs control   X 100 
                                                                                      Abs sample 
 
Where, Abs control is the absorbance of the control and Abs sample is the absorbance of the 
test sample. All the experiments were carried out in triplicates. The results are tabulated in 
Table 25,26 and Figs. 34, 35. 
METHOD III: IN VITRO ALPHA AMYLASE INHIBITION ASSAY 
The α-amylase is the one of the main enzymes in human that catalyses the hydrolysis 
of 1,4-glucosidic linkage of complex carbohydrates like starch into simple sugars namely, 
maltose. Inhibition of the α-amylase activity is one of the possible six mechanisms that can 
be potentially used for controlling diabetes. 
Controlling the glucose production from complex carbohydrates is considered to be 
effective in controlling diabetes. Although the inhibitory drug like acarbose is which inhibits 
α-amylase and α-glucosidase used in controlling glucose level in type 2 diabetic patients, the 
Chapter VII                                                          Pharmacological Evaluation 
Department of Pharmacognosy, MMC.   98 
 
acarbose has undesirable side effects, especially flatulence and diarrhea. Natural products 
extracted from plants are known to controlling hyperglycemia. The monoterpenes, 
sesquiterpenes, and oxygenic derivatives in herbal plant extracts are known to inhibit the 
activity of carbohydrate hydrolyzing enzymes. [173] 
Principle 
              Alpha amylase is the important enzymes involved in the digestion of carbohydrates. 
Alpha Amylase is involved in the breakdown of long chain carbohydrates. It serves as the 
major digestive enzymes and help in intestinal absorption. α-amylase inhibitors decrease the 
high glucose levels that can occur after a meal by slowing the speed with which alpha 
amylase can convert starch to simple sugars. This is of importance in diabetic people where 
low insulin levels prevent the fast clearing of extracellular glucose from the blood. Hence 
diabetics tend to have low alpha amylase levels in order to keep their glucose levels under 
control. Therefore alpha amylase inhibitors have potential roles in controlling blood sugar 
levels and crop protection. [174-177]. 
Fig.31:   Acarbose sites of action 
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Reagents 
 0.02M sodium phosphate buffer (pH 6.9 containing 6mM sodium chloride) 
 α-amylase solution (27.5mg of  α-amylase in 100ml 0f water) 
 1%, w/v soluble starch 
  1M HCl 
 Iodine reagent (5mM I2 and 5mM KI) 
Procedure 
              Various concentrations of methanolic extract of Citrullus lanatus 500μL were added 
to 500μL of 0.02M sodium phosphate buffer (pH 6.9 containing 6mM sodium chloride) 
containing 500μL of α-amylase solution and were incubated at 37°C for 10min. Then 500μL 
soluble starch (1%, w/v) was added to each reaction well and incubated at 37°C for 15min. 
1M HCl (20μL) was added to stop the enzymatic reaction, followed by the addition of 100μL 
of iodine reagent. The colour change was noted and the absorbance was read at 620nm. 
Acarbose was used as reference. Inhibition of enzyme activity was calculated as: Inhibition 
of enzyme activity (%) = (C-S) / C × 100, where S is the absorbance of the sample and C is 
the absorbance of blank (no extract).[190] . The results are tabulated in Table 27 and Fig. 36. 
METHOD IV: IN VITRO ALPHA GLUCOSIDASE INHIBITION ASSAY 
α-glucosidase catalyzes the final step in the digestive process of carbohydrates. Its 
inhibitors can retard the uptake of dietary carbohydrates and suppress postprandial 
hyperglycemia and could be useful for treating diabetic and/or obese patients (Toeller, 1994). 
α-Glucosidase inhibitors such as acarbose, miglitol, and voglibose are known to reduce 
postprandial hyperglycemia primarily by interfering with the carbohydrate digestive enzymes 
and by delaying glucose absorption. 
Acarbose a carbohydrate inhibitor, when administered showed delayed in glucose 
absorption Acarbose, an α-Glucosidase inhibitors, reduce intestinal absorption of 
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carbohydrate and there by blunt the postprandial rise in plasma glucose in diabetic patients. 
However flatulence and abdominal due to the malabsorption limits its potential as favoured 
medication. 
Principle 
               α-Glucosidase inhibitors are among the available glucose lowering medications. 
This enzyme is located in the brush border of the small intestine and is required for the 
breakdown of carbohydrates to absorbable monosaccharide. The α-Glucosidase inhibitors 
delay but do not prevent the absorption of ingested carbohydrates but reduce the postprandial 
glucose and insulin peak. [178-181]. 
 
Fig. 32: Mechanism of action of Alpha-glucosidase 
                     
Reagents 
 α- glucosidase (1U/ml). 
 0.2M  Tris buffer (pH 8.0). 
 GOD solution. 
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Procedure 
The enzyme α- glucosidase inhibitory activity is determined by incubating solution 
(0.1 ml) of an enzyme preparation with 0.2 M Tris buffer, pH 8.0 (1.0ml) containing 1mL of 
various concentrations of extract at 37 ºC for 60 minutes. The reaction mixture is heated for 
two minutes in boiling water bath to stop the reaction. The amount of liberated glucose is 
measured by glucose oxidation method. Acarbose was used as reference. [182-183]. The results 
are tabulated in Table 28 and Fig. 37. 
                (Enzyme activity of control – Enzyme activity of extract) 
% inhibition  =  ---------------------------------------------------------------------------- × 100 
                                              Enzyme activity of control 
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The plant extract possess good antioxidant activity and compared with the standard 
ascorbic acid. 
SECTION B - LARVICIDAL ACTIVITY OF METHANOLIC EXTRACT OF 
CITRULLUS LANATUS 
The results obtained for the larvicidal effect of methanolic extract of Citrullus lanatus 
are presented in Tables 18 to 20 and the graphical representations are presented in Figs. 25  
to 27.  
Table 18: Larvicidal activity of methanolic extract of Citrullus lanatus 
against Anopheles stephensi 
 
S. No Conc. (ppm) 
Log10  
Conc. 
Total 
No. 
No. 
Dead
% 
Mortality Probit Probit 
Regression 
value 
0 0 0 0 0 0 0 0 
1 25 1.40 20 3.00 15.00 3.77 3.00 4.358 
2 50 1.70 20 5.00 25.00 4.19 4.00 4.778 
3 100 2.00 20 6.00 30.00 4.36 4.00 4.948 
4 150 2.18 20 9.00 45.00 4.8 5.00 5.388 
5 200 2.30 20 10.00 50.00 4.92 5.00 5.508 
6 250 2.40 20 13.00 65.00 5.33 6.00 5.918 
7 300 2.48 20 16.00 80.00 5.81 6.00 6.398 
8 350 2.54 20 17.00 85.00 5.99 6.00 6.578 
9 400 2.60 20 19.00 95.00 6.65 7.00 7.238 
10 450 2.65 20 20.00 100.00 
LC50 84.23ppm  or  0.084v/v 
LC90 989.396ppm  or  0.989%v/v 
 
The LC50 (lethal concentration to cause 50% mortality in the population) and LC90 
(lethal concentration to cause 90% mortality in the population) were determined by plotting 
the regression line as described by Finney . The percentage mortality was calculated using 
Abbot’s formula and the data so obtained was analyzed by probit analysis (Finney 1989) by 
using the software Minitab-15 for dose and time mortality regression lines. The purpose of 
the probit transformation is to straighten the line so we can estimate LC 50 more easily. 
            From the Table 18 it can be observed that a mortality of 100.00 ± 0.00 was observed 
for Anopheles stephensi. The LC50 and LC90 values were calculated using Probit analysis. 
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The percentage mortality calculated using Abbott’s formula versus log concentration was 
plotted and Y=50 is substituted in the resulting linear equation to obtain the X value. The 
linear regression equation was found to be y = 37.387x - 21.988 for activity against 
Anopheles stephensi. The antilog of X was then the LC50 (conc. of 50% mortality) or LC90 
(conc. of 90% mortality) value.  
Fig. 25: Larvicidal activity of methanolic extract of Citrullus lanatus 
against Anonpheles stephensi 
 
                    
 
The LC50 was found to be 84.23ppm or 0.084v/v for Anopheles stephensi. The LC90 
value was found to be 989.3956ppm or 0.989%v/v for Anopheles stephensi. One hundred 
percent mortality was observed for the concentrations tested against the organisms. The 
extract was effective against Anopheles stephensi. 
From table 19, it can be observed that a mortality of 100.00 ± 0.00 was observed for 
Culex quinquefasciatus. The LC50 and LC90 values were calculated using Probit analysis. The 
percentage mortality calculated using Abbott’s formula versus log concentration was plotted 
and Y=50 is substituted in the resulting linear equation to obtain the X value. 
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Table 19: Larvicidal activity of methanolic extract of Citrullus lanatus 
against Culex quinquefasciatus 
 
S. No Conc. (ppm) 
Log10  
Conc. 
Total 
No. 
No. 
Dead
% 
Mortality Probit Probit 
Regression 
value 
0 0 0 0 0 0 0 0 0.00 
1 5 0.70 20 1.00 5.00 0 0.00 0.65 
2 10 1.00 20 1.00 5.00 0 0.00 0.65 
3 25 1.40 20 3.00 15.00 3.77 4.00 4.42 
4 50 1.70 20 6.00 30.00 4.36 4.00 5.01 
5 100 2.00 20 10.00 50.00 4.92 5.00 5.57 
6 150 2.18 20 13.00 65.00 5.33 5.00 5.98 
7 200 2.30 20 16.00 80.00 5.81 6.00 6.46 
8 250 2.40 20 17.00 85.00 5.99 6.00 6.64 
9 300 2.48 20 19.00 95.00 6.75 7.00 7.40 
10 350 2.54 20 20.00 100.00 
LC50 51.31ppm  or  0.051%v/v 
LC90 405.88ppm  or  0.405%v/v 
 
   The linear regression equation was found to be y = 44.533x - 26.161 for activity 
against Culex quinquefasciatus. The antilog of X was then the LC50 (conc. of 50 %mortality) 
or LC90 (conc. of 90% mortality) value. The LC50 was found to be 51.31ppm or 0.051%v/v 
for Culex quinquefasciatus. The LC90 value was found to be 405.88ppm or 0.405%v/v for 
Culex quinquefasciatus. One hundred percent mortality was observed for the concentrations 
tested against the organisms. The extract was effective against Culex quinquefasciatus 
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                   Fig. 26: Larvicidal activity of methanolic extract of Citrullus lanatus 
against Culex quinquefasciatus 
 
                  
                
Table 20: Larvicidal activity of methanolic extract of Citrullus lanatus 
against Aedes agypti 
 
S. 
No 
Conc. 
(ppm) 
Log10  
Conc. 
Total 
No. 
No. 
Dead
% 
Mortality Probit Probit 
Regression 
value 
0 0 0 0 0 0 0 0 0 
1 100 2.00 20 1.00 5.00 3.35 3.00 4.624 
2 150 2.18 20 1.00 5.00 3.35 3.00 4.624 
3 300 2.48 20 3.00 15.00 3.96 4.00 5.234 
4 500 2.70 20 4.00 20.00 4.16 4.00 5.434 
5 1000 3.00 20 6.00 30.00 4.48 4.00 5.754 
6 1500 3.18 20 7.00 35.00 4.62 5.00 5.894 
7 3000 3.48 20 9.00 45.00 4.87 5.00 6.144 
8 6000 3.78 20 10.00 50.00 5 5.00 6.274 
9 12000 4.08 20 18.00 90.00 6.28 6.00 7.554 
10 13000 4.11 20 20.00 100.00       
LC50 51.31ppm  or  0.051%v/v 
LC90 405.88ppm  or  0.405%v/v 
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Fig. 27: Larvicidal activity of methanolic extract of Citrullus lanatusagainst Aedes agypti 
                        
From the Table 20 it was observed that a mortality of 100.00 ± 0.00 was observed for 
Aedes agypti. The LC50 and LC90 values were calculated using Probit analysis. The 
percentage mortality calculated using Abbott’s formula versus log concentration was plotted 
and Y=50 is substituted in the resulting linear equation to obtain the X value. The linear 
regression equation was found to be y = 23.278x - 29.67 for activity against Aedes agypti. 
The antilog of X was then the LC50 (conc. of 50% mortality) or LC90 (conc. of 90% 
mortality) value.  
The LC50 was found to be 2645ppm or 2.645%v/v for Aedes agypti. The LC90 value 
was found to be 138326ppm or 138.326%v/v for Aedes agypti. One hundred percent 
mortality was observed for the concentrations tested against the organisms. The extract was 
effective against Aedes agypti. 
One hundred percent mortality was observed for various concentrations ranging for 
above organisms tested were observed within 24h of the start of the experiment. 
            In the present study, methanolic extract of Citrullus lanatus showed promising 
larvicidal activity against important vectors of malaria, filarial, dengue, dengue haemorrhagic 
fever, yellow fever, chikungunya. 
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             Mosquito control programmes largely target the larval stage at their breeding sites 
with larvicides. Larviciding is a successful method of reducing mosquito population in their 
breeding place before they emerge as adults. The screening of local medicinal plants for 
mosquito larvicidal activity may eventually lead to their use in natural product –based 
mosquito abatement practices. Plant extracts are reported to be eco-friendly mosquito control 
agents.  
Plants are well known to contain a complex of chemicals with bioactive potential like 
deterrents or attractants. Leaves are available throughout the year could be easily collected 
without any additional cost. Therefore, leaves extracts could be used as a larvicidal agent in 
an integrated vector control program.  
SECTION C - PANCREATIC LIPASE INHIBITION ASSAY 
          The results obtained for pancreatic lipase inhibition assay are presented in Table 21 
and the graphical representation is presented in Fig.28.  
Table 21:  Pancreatic lipase inhibition of MECL 
S. No Conc. in mg/ml 
% inhibition 
of Orlistat 
% inhibition 
of MECL 
1 1.0 20.91 ± 0.293 18.20 ± 0.306 
2 2.0 30.93 ± 0.583 26.40 ± 0.363 
3 3.0 40.23 ± 0.666 35.04 ± 0.416 
4 4.0 57.47 ± 0.490 52.90 ± 0.523 
5 5.0 73.63 ± 0.553 61.77 ± 1.102 
IC50 3.420 mg/mL 3.962 mg/mL 
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Fig.28: Determination Pancreatic lipase inhibition of MECL 
                     
From the table 21, it can be seen that the methanolic extract of Citrullus lanatus 
showed a percentage inhibition 61.77 ± 1.102 at a concentration of 5.0mg/mL. The IC50 
values calculated using the linear regression analysis was found to be 3.962mg/mL for 
methanolic extract of Citrullus lanatus. The Orlistat showed a percentage inhibition 73.63 ± 
0.553 at a concentration of 5.0 mg/mL, IC50 value was found to be 3.420mg/mL.  The extract 
of Citrullus lanatus possesses a good inhibitory activity on pancreatic lipase.  
The phytochemical screening of methanolic extract of Citrullus lanatus showed the 
presence of flavanoid, tannins, terpenes, phenols and saponins. Results of the study indicate 
that methanolic extract of Citrullus lanatus inhibits pancreatic lipase. The inhibitory activities 
of different concentration of Standard and methanolic extract of Citrullus lanatus were tested 
aginst chicken pancreatic lipase using olive oil as the substrate. 
The dose dependent pancreatic lipase inhibitory activity was observed. i.e inhibition 
of enzyme was increased on increasing concentration of extract. Polyphenols like flavanoids 
and tannins with an inhibitory effect on pancreatic lipase activity, which could be applied in 
the management of the obesity epidemic. 
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Overweight, obesity and weight change: Overweight (BMI ≥25 and < 30kg/m2)  or 
obese (BMI ≥ 30kg/m2 ) individual have a higher risk for many types of cancer compared 
with individuals whose BMI is considered within the normal range (18.5 to < 25 kg/m2 ). The 
cancers most consistently associated with overweight and obesity are breast, colon/rectum, 
endometrium, pancreas, adenocarcinoma of the esophagus, kidney, gallbladder, and liver. 
Obesity may also increase risk of mortality from some cancers, such as prostate. A 
growing body of evidence suggests that weight gain is associated with an increased risk of 
some cancers, breast cancer in particular. Increases in body weight during adulthood largely 
reflect increases in adipose tissue rather than lean mass. The total body fat may be a better 
measure of the risk for cancer than BMI. 
Studies over decades have consistently shown a strong association between obesity 
and both insulin resistance and type 2 diabetes incidence, with risk of diabetes and earlier age 
at onset directly linked to obesity severity. For type 2 diabetes as well as certain cancers, 
some studies suggest that waist circumference, waist –to-hip ratio, or direct measures of 
visceral adiposity with risk independently of BMI. 
The case for a causal relationship between obesity and disease is strengthened by 
evidence that weight loss lowers disease risk. In the case of diabetes, numerous studies have 
shown that weight loss decreases diabetes incidence and restores euglycemia in a significant 
fraction of individuals with type 2 diabetes. In the randomised, prospective, multicenter 
Diabetes prevention program trial, an intensive lifestyle intervention of diet and physical 
activity was associated with a 58% reduction in diabetes incidence in high risk individuals, 
and weight loss accounted for most of the effect. 
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Several studies suggest that diets high in foods with a high glycemic index or load are 
associated with an increased risk of type 2 diabetes. However evidence of their associations 
with cancer risk is mixed.  
SECTION D - IN VITRO ANTI CANCER ACTIVITY (BREAST CANCER 
ACTIVITY BY USING HUMAN BREAST CANCER CELL LINES)  
The iIn vitro anti-cancer (breast cancer) activity of methanolic extract of Citrullus 
lanatus  (MECL) is tabulated in Table 22 & 23 
Table 22: Various concentration and Absorbance of the MECL 
  
 
 
 
Table 23:  Percentage Cell viability of  Methanolic extract of Citrullus lanatus. 
 
 
 
 
 
Conc 18.75 µg/mL 
37.5 
µg/mL 
75 
µg/mL 
150 
µg/mL 
300 
µg/mL Control 
ABS 0.316 0.313 0.299 0.293 0.277 0.305 
0.308 0.305 0.3 0.287 0.269 0.307 
0.31 0.292 0.292 0.285 0.279 0.309 
Avg 0.311 0.303 0.297 0.288 0.275 0.307 
S. No Conc. (µg/ml) % Cell viability % Inhibition 
1 18.75 101.411 0.00 
2 37.50 98.805 1.20 
3 75.00 96.742 3.25 
4 150.00 93.919 6.08 
5 300.00 89.576 10.42 
                 Fig.30:   Photomicrograph of  human breast cancer cell lines (MCF-7) 
MECL at 18.75µg/mL                                MECL at 37.50µg/mL 
                                          
            MECL at 75µg/mL     MECL  at 150µg/mL  
 
                             
MECL  at 300µg/mL                         Control                                           
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Fig. 29:  Percentage Cell viability of methanolic extract of Citrullus lanatus.
 
 The MECL showed a slight cytotoxic activity against human breast cancer cell lines 
MCF-7 at 300µg/mL with a cell viability of 89.57%. The percentage inhibition was found to 
be 10.42% at the concentration of 300µg/mL. The breast cancer activity was determined on 
human breast cancer cell lines MCF-7. The extract did not show a significant anticancer 
activity.   
SECTION E - IN VITRO ANTIDIABETIC ACTIVITY 
METHOD I : NON-ENZYMATIC GLYCOSYLATION OF HAEMOGLOBIN ASSAY 
The results for in vitro non enzymatic glycosylation of haemoglobin assay are presented in 
Table 24 and the graphical representation of the same in Fig. 31. The percentage inhibition 
was found to be 72.398 ± 0.221 and 76.171 ± 0.213 for MECL and α-tocopherol respectively. 
The IC50 value calculated using linear regression analysis was found to be 65.648 µg/mL and 
59.762 µg/mL for MECL and α-tocopherol respectively. 
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Table 24:  In-vitro Non-enzymatic glycosylation of haemoglobin method 
S. 
No 
Conc. 
in 
µg/ml 
α-Tocopherol Methanolic extract of Citrullus lanatus 
Abs % inhibition Abs % inhibition 
1 20 0.159 ± 0.003 23.270 ± 1.674 0.147 ± 0.000 17.006 ± 0.496
2 40 0.187 ± 0.002 34.759 ± 1.016 0.169 ± 0.004 27.810 ± 1.847
3 60 0.258 ± 0.004 52.713 ± 0.813 0.233 ± 0.002 47.639 ± 0.589
4 80 0.386 ± 0.004 68.393 ± 0.342 0.346 ± 0.005 64.739 ± 0.623
5 100 0.512 ± 0.004 76.171 ± 0.213 0.442 ± 0.003 72.398 ± 0.221
IC50  Value 59.762 µg/mL 65.648 µg/mL 
 * mean of three readings ±SEM 
Fig.33 :  In-vitro Non-enzymatic glycosylation of haemoglobin method 
           
           Plant extracts play an important role the inhibition of the glycosylation end products. 
An increase in the glycosylation was observed on incubation of hemoglobin with the 
increasing concentration of the glucose over a period of 72hrs. However, the plant extracts 
significantly inhibited the haemoglobin glycosylation which is indicated by the presence of 
increasing concentration of haemoglobin. Citrullus lanatus exhibited significant inhibition of 
glycosylation as compared with the standard drug α-tocopherol. The plant extracts also 
displayed the inhibition of haemoglobin glycosylation at different physiological 
concentrations of the glucose over the period of 72hrs, indicating that the plant extracts 
0
20
40
60
80
100
0 50 100 150
%
 in
hi
bi
tio
n
Concentration (µg/ml)
Non‐enzymatic glycosylation of haemoglobin 
method
% inhibition 
of Vitamin E
% inhibition 
0f MECL
Chapter VII                                                          Pharmacological Evaluation 
Department of Pharmacognosy, MMC.   117 
 
decreases the formation of the glucose- haemoglobin complex and thus amount of free 
haemoglobin increases. 
METHOD II: IN-VITRO GLUCOSE UPTAKE IN YEAST CELLS 
             The rate of glucose transport across cell membrane in yeast cells system is presented 
in Figs. 34 & 35, tables 25 & 26. 
Table 25:  Percentage inhibition of Glucose uptake in 5mM glucose concentrations 
S. 
No 
Conc. 
µg/ml 
Acarbose Methanolic extract of Citrullus lanatus 
Abs % inhibition Abs % inhibition 
1 40 0.102 ± 0.001 60.78 ± 0.220 0.099  ± 0.002 59.60 ± 0.386
2 80 0.117  ± 0.000 65.81 ± 0.222 0.106  ±0.002 62.26 ± 0.030
3 120 0.132  ± 0.001 69.70 ± 0.271 0.124  ± 0.003 67.74 ± 0.204
4 160 0.150 ± 0.002 73.33 ± 0.101 0.140  ± 0.001 71.43 ± 0.177
5 200 0.188  ±0.002 78.72 ± 0.248 0.152 ± 0.006 73.68 ± 0.362
IC50  Value 74.083   µg/mL 80.218 µg/mL 
              * mean of three readings ±SEM 
Fig.34 :  % inhibition of Glucose uptake at 5mM concentration 
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Table 26:  Percentage inhibition of Glucose uptake at 10mM concentration 
S. 
No 
Conc.  
µg/ml 
Acarbose Methanolic extract of Citrullus lanatus 
Absorbance % inhibition Absorbance % inhibition 
1 40 0.200 ± 0.003 65.00 ± 0.242 0.170 ± 0.004 58.82 ± 0.257 
2 80 0.214 ± 0.002 67.28 ± 0.163 0.220 ± 0.001 65.00 ± 0.282 
3 120 0.249 ± 0.004 71.88 ± 0.178 0.248 ± 0.001 68.54 ± 0.081 
4 160 0.303 ± 0.003 76.89 ± 0.206 0.311 ± 0.003 73.28 ± 0.077 
5 200 0.379 ± 0.001 81.53 ± 0.181 0.335 ± 0.003 76.74 ± 0.214 
IC50  Value 67.408 µg/mL 77.031 µg/mL 
 * mean of three readings ±SEM 
The percentage inhibition was found to be 76.74 ± 0.214 and 81.53 ± 0.181 for 
MECL and acarbose at 200µg/mL respectively. The IC50 value calculated using linear 
regression analysis was found to be 77.031µg/mL and 67.408 µg/mL for MECL and 
acarbose respectively 
Fig. 35:  % inhibition of Glucose uptake in 10mM glucose concentrations 
                  
                Regulation of glucose level in the blood of the diabetic patient can prevent the 
various complications associated with the disease. The maintenance of plasma glucose 
concentration for a long term under a variety of dietary conditions is one of the most 
important and closely regulated processes observed in the mammalian species. The in vitro 
0
20
40
60
80
100
0 50 100 150 200 250
%
 in
hi
bi
tio
n
Concentration (µg/ml)
% inhibition of Glucose uptake in 10mM glucose 
concentrations
% 
inhibition 
of 
Acarbose
Chapter VII                                                          Pharmacological Evaluation 
Department of Pharmacognosy, MMC.   119 
 
assays of the present study indicated the methanolic extract of Citrullus lanatus possess good 
anti diabetic activity. In yeast, glucose transport takes place through facilitated diffusion. 
Type 2 Diabetes is characterised by the deficiency of insulin causing increased amount of 
glucose in blood. After the treatment of the yeast cells with these leaf extracts, the glucose 
uptake was found to increase in a dose dependent manner. The Figs.32 & 33 depict the % 
increase in glucose uptake by the yeast cell at different glucose concentrations i.e.5mM and 
10mM respectively. The methanolic extract of Citrullus lanatus exhibited significantly higher 
activity at all glucose concentrations showing the maximum increase in 10mM Glucose 
concentration. Results also indicated that Citrullus lanatus  had greater efficiency in 
increasing the glucose uptake by yeast cells as compared to standard drug Acarbose. 
METHOD III -IN-VITRO ALPHA AMYLASE INHIBITION METHOD 
The α-amylase inhibitor effectiveness of methanolic extracts of the Citrullus lanatus 
was compared with Acarbose reference standard on the basis of their resulting IC50 values 
inhibited the activity of α-amylase with an IC50 of methanolic extract of Citrullus lanatus was 
47.880 µg/mL. Acarbose, the positive control used in this study, inhibited the activity of α-
amylase with an IC50 value estimated at 58.558µg/mL.  The values are presented in Table 27 
and Fig. 34.  
Table 27:  In-vitro Alpha amylase inhibition 
S. 
No 
Conc. 
µg/ml 
Acarbose Methanolic extract of Citrullus lanatus 
Absorbance % inhibition Absorbance % inhibition 
1 20 0.099 ± 0.001 44.44 ± 0.646 0.077 ± 0.003 28.57 ± 3.185 
2 40 0.116 ± 0.004 52.58 ± 1.751 0.103 ± 0.002 46.60 ± 1.020 
3 60 0.152 ± 0.003 63.81 ± 0.844 0.128 ± 0.004 57.03 ± 1.341 
4 80 0.193 ± 0.002 71.50 ± 0.340 0.154 ± 0.003 64.28 ± 0.768 
5 100 0.232 ± 0.006 76.29 ± 0.658 0.186 ± 0.002 69.44 ± 0.410 
IC50  Value 47.880 µg/mL 58.558 µg/mL 
 * mean of three readings ±SEM 
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Fig. 36:  In-vitro Alpha amylase inhibition method 
 
             The percentage inhibition was found to be 69.44 ± 0.410and 76.29 ± 0.658 for 
MECL and acarbose at 100µg/mL respectively. The IC50 value calculated using linear 
regression analysis was found to be 58.558 µg/mL and 47.880 µg/mL for MECL and 
acarbose respectively 
Alpha amylase is an enzyme that hydrolyses alphabonds of large alpha linked 
polysaccharide such as glycogen and starch to yield glucose and maltose. Alpha amylase 
inhibitors bind to alpha- bond of polysaccharide and prevent break down of polysaccharide in 
mono and disaccharide. As the result shows methanolic extract of Citrullus lanatus 
significant activity as compared to acarbose standard drug. 
             Drugs that inhibit carbohydrate hydrolyzing enzymes have been demonstrated to 
decrease postprandial hyperglycemia and improve impaired glucose metabolism without 
promoting insulin secretion of non insulin dependent diabetic patients. The results of in vitro 
studies showed that Citrullus lanatus inhibits α-amylase activity. Natural health products of 
vegetable origin were clearly indicated as a promising avenue for the prevention of chronic 
diseases (Punitha & Manoharan 2006). 
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METHOD IV -  IN-VITRO ALPHA GLUCOSIDASE INHIBITION METHOD 
The values for in vitro alpha glucosidase inhibition are presented in Table 28 and 
Fig.35.  
                     Table 28:  In-vitro α-glucosidase inhibition assay 
                                      
 
 
 
 
                  
*                                      
mean of three readings ±SEM 
Fig. 37 :  In-vitro α-glucosidase inhibition assay 
                          
               The α-glucosidase inhibitor effectiveness of methanolic extracts of the Citrullus 
lanatus was compared with acarbose reference standard on the basis of their resulting IC50 
values inhibited the activity of α-glucosidase with an IC50 of methanolic extract of Citrullus 
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S. 
No 
Conc. 
µg/ml 
Acarbose Methanolic extract of Citrullus lanatus 
Absorbance % inhibition Absorbance % inhibition 
1 200 0.809 ± 0.004 24.46 ± 0.457 0.896 ± 0.002 16.34 ± 0.189 
2 400 0.519 ± 0.002 51.54 ± 0.188 0.780 ± 0.001 27.17 ± 0.136 
3 600 0.388 ± 0.001 63.77 ± 0.113 0.517 ± 0.002 51.73 ± 0.270 
4 800 0.216 ± 0.001 79.83 ± 0.136 0.408 ± 0.002 61.90 ± 0.188 
5 1000 0.106 ± 0/002 90.10 ± 0.243 0.204 ± 0.002 80.95 ± 0.273 
IC50  Value 482.188  µg/mL 627.270  µg/mL 
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lanatus was 627.270µg/mL. Acarbose, the positive control used in this study, inhibited the 
activity of α-glucosidase with an IC50 value estimated at  482.188µg/mL.   
In Diabetes mellitus, control of postprandial plasma glucose level is critical in the 
early treatment. An inhibition of enzymes involved in the metabolism of carbohydrate is one 
of the therapeutic approaches for reducing postprandial hyperglycemia. 
α-glucosidase is a key enzyme in carbohydrate digestion. It catalyzes the hydrolysis of 
1,4-α-glucosidic bonds within carbohydrates with release of α-glucose and promotes the 
increase of blood glucose level after meal. α-glucosidase inhibitors antagonize the activity of 
α-glucosidase, thereby delaying intestinal carbohydrate absorption and slowing the sharp rise 
in blood sugar levels that diabetic patients typically experience after meals. For this reason, 
α-glucosidase inhibitors, such as acarbose and voglibose, are clinically used as oral 
antihyperglycemic agents. However, they often cause severe gastrointestinal side effects. 
Therefore, search for new α-glucosidase inhibitors from natural resources has become an 
attractive approach for the treatment of postprandial hyperglycemia. 
 In the present study, methanolic extract of Citrullus lanatus was screened for their 
alpha-glucosidase inhibitory potential. The extract showed better alpha-glucosidase inhibition 
property. Alpha-glucosidase inhibitors have a potential for the treatment of diabetes because 
they reduce diet-induced hyperglycemia. 
           The extract possessed a significant in vitro antidiabetic acitivity and hence in vivo 
studies are further required for providing a scientific information on the plant.  
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CHAPTER VIII 
SUMMARY AND CONCLUSION 
The present study entitled the “Pharmacognostic, Phytochemical and 
Pharmacological evaluation of the Leaves of Citrullus lanatus (Thunb.) Matsum. & 
Nakai. (Cucurbitaceae)” focuses on a plant which is commonly available throughout India 
and traditionally used in treatment of various ailments.     
 Studies on the leaves of Citrullus lanatus are still lacking. Hence to exploit its 
potential use prompted the present study to investigate the leaves of this plant with clear 
scientific protocol. 
The chapter on Literature Review deals with the information regarding the 
pharmacognostical, phytochemical and pharmacological evaluation of the Citrullus lanatus 
plant and other  species of Citrullus. 
            The chapter on Pharmacognostical studies highlights on  
 Macroscopical features were studied and the adherence of general characters to the 
family Citrullus lanatus was found. 
 Microscopical study reveals the presence of actinocytic stomata, multi cellular 
uniseriate unbranched epidermal trichomes. Vascular system of the midribis 
multistranded, a large abaxial median bundle, two adaxial bundle. All the bundles are 
bicollateral having phloem strand both outer and inner side of the xylem. The 
epidermal cells are small elliptical or rectangular and thin walled. Spongy 
parenchyma cells small and spherical. Palisade zone consist of single layer of 
cylindrical cells, loosely arranged.  
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 Quantitative microscopical studies namely stomatal number, stomatal index, vein islet 
number, vein termination number, ash value, extractive value, loss on drying value 
etc., 
 Also studied cell powder microscopy, fluorescence analysis of powder and the results 
helps in achieving a trouble-free identification and authenticity of the plant leaf or in 
powder form in future.  
           The chapter on Phytochemical Evaluation deals with 
 Preliminary phytochemical screening reveals the presence of  carbohydrate, alkaloids, 
flavanoids, protein & aminoacids, glycosides etc., 
 Quantitative determination of secondary metabolites ( phenol, flavanoid, tannin 
content) has been carried out. 
 TLC & HPTLC studies showed the presence of flavanoid, phenolic compound and  
tannin. In HPTLC studies the extract was compared with standards and the presence 
of  quercetin, gallic aci and catechin were formed. 
 The vitamin B1, B2  and vitamin C were estimated. 
 
The chapter on Pharmacological studies focuses 
 The Antioxidant activity by various methods and the extract possessed a good 
antioxidant property due to the presence of Vitamin-C, poly phenolic, flavonoid 
content. 
 The larvicidal effect of extract of the Citrullus lanatus  was carried out by standard 
procedure. In the present study, methanolic extract of citrullus lanatus showed 
promising larvicidal activity aginst important vectors of malaria, filariasis, dengue, 
dengue haemorrhagic fever, yellow fever. 
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 Obesity can lead to variety serious diseases, including hypertension, hyperlipidemia, 
atherosclerosis, and type II diabetes. The pancreatic lipase inhibitors of digestive 
lipases reduce dietary fat absorption and hence act as anti-obesity agents. The 
Citrullus lanatus extract have a capacity to inhibit the pancreatic lipase.  
 The extract showed anti cancer (breast cancer) activity aginst human breast cancer 
cell lines (MCF-7) which was evaluated by MTT assay. The risk of breast cancer 
increases gradually as a woman gets older. The high concentration of the MECL used 
for inhibiting human breast cancer cell lines (MCF-7). Type 2 diabetes and breast 
cancer share many risk factors. The extract Citrullus lanatus showed high antidiabetic 
activity with high concentration showed breast cancer activity. 
 The antidiabetic activity of extract of the leaves of Citrullus lanatus was carried out 
by Non-enzymatic glycosylation of haemoglobin Assay method, Glucose uptake in 
yeast cells method ( % inhibition of Glucose uptake in 5mM glucose concentrations & 
% inhibition of Glucose uptake in 10mM glucose concentrations ) Alpha amylase 
inhibition assay method & Alpha glucosidase inhibition assay method. The extract 
showed better alpha-glucosidase inhibition property. 
 The extract exhibit significant inhibition of glycosylation as compared with the  
standard drug alpha tocopherol. Decreases the formation of the  glucose- haemoglobin 
complex and thus amount of free haemoglobin increases. 
 The extract showed greater efficiency in increasing the glucose uptake by yeast cells 
as compared to standard drug Acarbose. Type 2 Diabetes is characterised by the deficiency of 
insulin causing increased amount of glucose in blood. After the treatment of the yeast cells 
with these leaf extracts, the glucose uptake was found to increase in a dose dependent 
manner. 
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Alpha amylase inhibitors bind to alpha- bond of polysaccharide and prevent break 
down of polysaccharide in mono and disaccharide. The result showed extract of Citrullus 
lanatus significant activity as compared to acarbose standard drug. 
Alpha-glucosidase inhibitors have a potential for the treatment of diabetes because 
they reduce diet-induced hyperglycemia. The extract showed better alpha-glucosidase 
inhibition property.  
The in vitro assays of the present study indicated the methanolic extract of Citrullus 
lanatus  possess good anti diabetic activity. 
 Citrallus lanatus (water melon) is popular in indigenous system of folk medicine. The 
leaf extract of Citrullus lanatus contain bioactive compounds such as flavanoid, 
phenolic compound, tannin, triterpenes, sterols and alkaloids, vitamins. The extract 
may serve as a lead medicinal plant to synthesise various semi-synthetic drugs to treat 
various life threatening disease. 
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